Staff Publications: December 2018

  1. Al-Hebshi NN, Nasher AT, Maryoud MY, et al. Inflammatory Bacteriome Featuring Fusobacterium Nucleatum and Pseudomonas Aeruginosa Identified in Association with Oral Squamous Cell Carcinoma. Sci Rep. 2017;7(1):1834. PMID: 28500338. PMC5431832.
  2. Bai T, Chanda AK, Egleston BL, Vucetic S. EHR Phenotyping via Jointly Embedding Medical Concepts and Words into a Unified Vector Space. BMC Med Inform Decis Mak. 2018;18(Suppl 4):123. PMID: 30537974. PMC6290514.
  3. Bair SM, Strelec LE, Feldman TA, et al. Outcomes and Toxicities of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real-World, Multicenter Retrospective Analysis. Oncologist. 2018. PMID: 30568021.
  4. Bergman A, Gligorijevic B. Real-Time Imaging of Invadopodia in Tumor Microenvironment Context. (2018) Optics InfoBase Conference Papers, Part F89-MICROSCOPY 2 p.
  5. Cheson BD, O’Brien S, Ewer MS, et al. Optimal Management of Adverse Events from Copanlisib in the Treatment of Patients with Non-Hodgkin Lymphomas. Clin Lymphoma Myeloma Leuk. 2018. PMID: 30584024.
  6. Correa AF, Yankey H, Li T, et al. Renal Hilar Lesions: Biological Implications for Complex Partial Nephrectomy. Urology. 2019;123:174-180. PMID: 30296503.
  7. de Prisco N, Stout E, Font-Burgada J. Specific Labeling and Lineage Tracing of Periportal Hepatocytes Using Two-Step Genetic Recombination. Methods Mol Biol. 2019;1905:59-70. PMID: 30536090.
  8. Dignam JJ, Hamstra DA, Lepor H, et al. Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202. J Clin Oncol. 2018:JCO1800154. PMID: 30526194.
  9. Dyer KE, Shires DA, Flocke SA, et al. Patient-Reported Needs Following a Referral for Colorectal Cancer Screening. Am J Prev Med. 2018. PMID: 30554975.
  10. Edwards DC, Cahn DB, Reddy M, et al. Incisional Hernia after Cystectomy: Incidence, Risk Factors and Anthropometric Predisposition. Can J Urol. 2018;25(6):9573-9578. PMID: 30553281.
  11. Ghatalia P, Zibelman MR, Geynisman DM, Plimack ER. Evolving Landscape of the Treatment of Metastatic Clear Cell Renal Cell Carcinoma. Clin Adv Hematol Oncol. 2018;16(10):677-686. PMID: 30543598.
  12. Gotlib J, Gerds AT, Bose P, et al. Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(12):1500-1537. PMID: 30545997.
  13. Gounder MM, Mahoney MR, Van Tine BA, et al. Sorafenib for Advanced and Refractory Desmoid Tumors. N Engl J Med. 2018;379(25):2417-2428. PMID: 30575484.
  14. Graves KD, Hall MJ, Tercyak KP. Introduction to the Special Issue on Clinical and Public Health Genomics: Opportunities for Translational Behavioral Medicine Research, Practice, and Policy. Transl Behav Med. 2018;8(1):4-6. PMID: 29385593. PMC6065537.
  15. Haddad RI, Nasr C, Bischoff L, et al. NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018. J Natl Compr Canc Netw. 2018;16(12):1429-1440. PMID: 30545990.
  16. Hendifar AE, Petzel MQB, Zimmers TA, et al. Pancreas Cancer-Associated Weight Loss. Oncologist. 2018. PMID: 30591550.
  17. Hernandez Borrero LJ, Sikder R, Lulla A, et al. Bcl-2 Protein Targeting by the P53/P21 Complex-Letter. Cancer Res. 2018;78(10):2770-2771. PMID: 29703721.
  18. Heyza JR, Arora S, Zhang H, et al. Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells. Nutrients. 2018;10(11). PMID: 30400270. PMC6267282.
  19. Ito T, Derweesh IH, Ginzburg S, et al. Perioperative Outcomes Following Partial Nephrectomy Performed on Patients Remaining on Antiplatelet Therapy. J Urol. 2017;197(1):31-36. PMID: 27418453.
  20. Jones CE, Hammer AM, Cho Y, et al. Stromal PTEN Regulates Extracellular Matrix Organization in the Mammary Gland. Neoplasia. 2019;21(1):132-145. PMID: 30550871. PMC6293034.
  21. Kasagi Y, Dods K, Wang JX, et al. Fibrostenotic Eosinophilic Esophagitis May Reflect Epithelial Lysyl Oxidase Induction by Fibroblasts-Derived Tumor Necrosis Factor-Alpha. J Allergy Clin Immunol. 2018. PMID: 30578874.
  22. Kluetz PG, Kanapuru B, Lemery S, et al. Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an Fda and Critical Path Institute Workshop. Value Health. 2018;21(6):742-747. PMID: 29909880.
  23. Kozlova AL, Valieva ME, Maluchenko NV, Studitsky VM. HMGB Proteins as DNA Chaperones That Modulate Chromatin Activity. Molecular Biology. 2018;52(5):637-647.
  24. Liao L, Alicea-Velazquez NL, Langbein L, et al. High Affinity Binding of H3K14AC through Collaboration of Bromodomains 2, 4, and 5 is Critical for the Molecular and Tumor Suppressor Functions of PBRM1. Mol Oncol. 2018. PMID: 30585695.
  25. Lin T, Hossain M, Fan J, Ma CC. When and How to Treat an IMRT Patient on a Second Accelerator without Replanning? Med Dosim. 2018;43(4):334-343. PMID: 29287919.
  26. Liu B, Tang L, Zhang X, et al. A Cell-Based High Throughput Screening Assay for the Discovery of CGAS-STING Pathway Agonists. Antiviral Res. 2017;147:37-46. PMID: 28982551. PMC5789800. NIHMS911402.
  27. Lu H, Liu S, Zhang G, et al. Author Correction: PAK Signalling Drives Acquired Drug Resistance to MAPK Inhibitors in BRAF-Mutant Melanomas. Nature. 2019;565(7738):E4. PMID: 30532003.
  28. MacFawn I, Wilson H, Selth LA, et al. Grainyhead-Like-2 Confers NK-Sensitivity through Interactions with Epigenetic Modifiers. Mol Immunol. 2018;105:137-149. PMID: 30508726.
  29. Magnius L, Taylor J, Mason WS, et al. ICTV Virus Taxonomy Profile: Deltavirus. J Gen Virol. 2018;99(12):1565-1566. PMID: 30311870.
  30. Martin JM, Wu H, Barta SK. Cd30+ T-Cell Lymphoproliferative Disorders. Chin Clin Oncol. 2018. PMID: 30525751.
  31. Mavaddat N, Michailidou K, Dennis J, et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. Am J Hum Genet. 2019;104(1):21-34. PMID: 30554720.
  32. Ming M, Wu W, Xie B, et al. XPO1 Inhibitor Selinexor Overcomes Intrinsic Ibrutinib Resistance in Mantle Cell Lymphoma via Nuclear Retention of IκB. Mol Cancer Ther. 2018;17(12):2564-2574. PMID: 3051014.
  33. Mortazavi SAR, Kadivar F, Mortazavi SMJ. Comments on, “A Narrative Review of Interventions for Improving Sleep and Reducing Circadian Disruption in Medical Inpatients”. Sleep Med. 2018. PMID: 30503687.
  34. Parham LR, Williams PA, Chatterji P, Whelan KA, Hamilton KE. RNA Regulons Are Essential in Intestinal Homeostasis. Am J Physiol Gastrointest Liver Physiol. 2019;316(1):G197-G204. PMID: 30520692.
  35. Pourfarhangi KE, Bayarmagnai B, de la Hoz EC, Cohen A, Gligorijevic B. A Methodology to Investigate the Relationship between Cancer Cells Cell-Cycle Phase and Their Migratory Behaviors. Optics InfoBase Conference Papers, Part F91-TRANSLATIONAL. 2 p. 2018.
  36. Prabhu VV, Madhukar NS, Gilvary C, et al. Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism. Clin Cancer Res. 2018. PMID: 30559168.
  37. Ramos JD, Wingate JT, Gulati R, et al. Venous Thromboembolism Risk in Patients with Locoregional Urothelial Tract Tumors. Clin Genitourin Cancer. 2017;16(1):e161-e167. PMID: 28923700. PMC5826750.
  38. Redner RL, Beumer JH, Kropf P, et al. A Phase-1 Study of Dasatinib plus All-Trans Retinoic Acid in Acute Myeloid Leukemia. Leuk Lymphoma. 2018;59(11):2595-2601. PMID: 29616864. PMC6201295.
  39. Reese JB, Smith KC, Handorf E, et al. A Randomized Pilot Trial of a Couple-Based Intervention Addressing Sexual Concerns for Breast Cancer Survivors. J Psychosoc Oncol. 2018:1-22. PMID: 30580675.
  40. Reese JB, Sorice KA, Oppenheimer NM, et al. Why Do Breast Cancer Survivors Decline a Couple-Based Intimacy Enhancement Intervention Trial? Transl Behav Med. 2018. PMID: 30544201.
  41. Roethke SK, Ryan JC, Wood SY. Management of Older Patients with Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario. J Adv Pract Oncol. 2018;9(1):67-76. PMID: 30564469. PMC6296420.
  42. Roussi P, Miller SM, Giri VN, et al. Effects of a Randomized Trial Comparing Standard and Enhanced Counseling for Men at High Risk of Prostate Cancer as a Function of Race and Monitoring Style. J Health Psychol. 2016;23(14):1359105316671188. PMID: 28810355. PMC5561513.
  43. Shulman RM, Meyer JE, Li T, Howell KJ. External Beam Radiation Therapy (EBRT) for Asymptomatic Bone Metastases in Patients with Solid Tumors Reduces the Risk of Skeletal-Related Events (SRES). Ann Palliat Med. 2018. PMID: 30525770.
  44. Su Y, Hopfinger NR, Nguyen TD, Pogash TJ, Santucci-Pereira J, Russo J. Epigenetic Reprogramming of Epithelial Mesenchymal Transition in Triple Negative Breast Cancer Cells with DNA Methyltransferase and Histone Deacetylase Inhibitors. J Exp Clin Cancer Res. 2018;37(1):314. PMID: 30547810. PMC6295063.
  45. Walpole S, Pritchard AL, Cebulla CM, et al. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide. J Natl Cancer Inst. 2018;110(12):1328-1341. PMID: 30517737. PMC6292796.
  46. White MN, Dotan E, Catalano PJ, Cardin DB, Berlin JD. Advanced Pancreatic Cancer Clinical Trials: The Continued Underrepresentation of Older Patients. J Geriatr Oncol. 2018. PMID: 30573201.
  47. Wickersham KE, Hodges TK, Edelman MJ, Song Y, Nan M, Dorsey SG. Differential Gene Expression in Erlotinib-Treated Fibroblasts. Nurs Res. 2018. PMID: 30540703.
  48. Winer A, Adams S, Mignatti P. Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures into Future Successes. Mol Cancer Ther. 2018;17(6):1147-1155. PMID: 29735645. PMC5984693.
  49. Zaorsky NG, Lehrer EJ, Handorf E, Meyer JE. Dose Escalation in Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Meta-Analysis. Am J Clin Oncol. 2019;42(1):46-55. PMID: 29965809.
Advertisements

Staff Publications: October 2018

  1. Amin A, Plimack ER, Ernstoff MS, et al. Safety and Efficacy of Nivolumab in Combination with Sunitinib or Pazopanib in Advanced or Metastatic Renal Cell Carcinoma: The Checkmate 016 Study. J Immunother Cancer. 2018;6(1):109. PMID: 30348216. PMC6196426.
  2. Arora S, Heyza JR, Chalfin EC, Ruch RJ, Patrick SM. Gap Junction Intercellular Communication Positively Regulates Cisplatin Toxicity by Inducing DNA Damage through Bystander Signaling. Cancers (Basel). 2018;10(10). PMID: 30279363. PMC6210410.
  3. Badar T, Hamadani M, Bachanova V, et al. Efficacy of Salvage Chemotherapy in Diffuse Large B Cell Lymphoma with Primary Treatment Failure According to Putative Cell of Origin. Leuk Lymphoma. 2018:1-7. PMID: 30277110.
  4. Barone FC, Marcinkiewicz C, Li J, et al. Pilot Study on Biocompatibility of Fluorescent Nanodiamond-(NV)-Z~800 Particles in Rats: Safety, Pharmacokinetics, and Bio-Distribution (Part III). Int J Nanomedicine. 2018;13:5449-5468. PMID: 30271140. PMC6149985.
  5. Bartel MJ, Tokar JL. Non-Lifting Colorectal Neoplasia – Shall We CAST It Away? Endoscopy. 2018;50(1):6-7. PMID: 29268294.
  6. Battistuzzi FU, Tao Q, Jones L, Tamura K, Kumar S. RelTime Relaxes the Strict Molecular Clock Throughout the Phylogeny. Genome Biol Evol. 2018;10(6):1631-1636. PMID: 29878203. PMC6022624. .
  7. Bevelacqua JJ, Mortazavi SMJ. Commentary Regarding “on-Orbit Sleep Problems of Astronauts and Countermeasures”. Mil Med Res. 2018;5(1):38. PMID: 30376883. PMC6208067.
  8. Chakraborty H, Mogurampelly S, Yadav VK, Waghmare UV, Klein ML. Phonons and Thermal Conducting Properties of Borocarbonitride (BCN) Nanosheets. Nanoscale. 2018;10(47):22148-22154. PMID: 30357208.
  9. Chauhan N, Bukovcan J, Boucher E, et al. Intra-Arterial Therasphere Yttrium-90 Glass Microspheres in the Treatment of Patients with Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial. Journal of Medical Internet Research. 2018;20(8):e11234. PMID: 30111528. PMC6115595.
  10. Chernoff J. How to Get and Keep Your Lab Funded. Mol Biol Cell. 2018;29(21):2519-2521. PMID: 30325287.
  11. Correa AF, Yankey H, Li T, et al. Renal Hilar Lesions: Biological Implications for Complex Partial Nephrectomy. Urology. 2018. PMID: 30296503.
  12. Cristescu R, Mogg R, Ayers M, et al. Pan-Tumor Genomic Biomarkers for PD-1 Checkpoint Blockade-Based Immunotherapy. Science. 2018;362(6411). PMID: 30309915.
  13. Crook JM, Zhang P, Pisansky TM, et al. A Prospective Phase Ii Trial of Trans-Perineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer after External Beam Radiotherapy (NRG Oncology/RTOG -0526). Int J Radiat Oncol Biol Phys. 2018. PMID: 30312717.
  14. Denlinger CS, Sanft T, Baker KS, et al. Survivorship, Version 2.2018 Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2018;16(10):1216-1247. PMID: 30323092.
  15. Doss M. Letter by Doss Regarding Article, “Exposure to Low-Dose Ionizing Radiation from Cardiac Procedures and Malignancy Risk in Adults with Congenital Heart Disease”. Circulation. 2018;138(13):1375-1376. PMID: 30354420.
  16. Dow M, Pyke RM, Tsui BY, et al. Integrative Genomic Analysis of Mouse and Human Hepatocellular Carcinoma. Proc Natl Acad Sci U S A. 2018;115(42):E9879-e9888. PMID: 30287485. PMC6196518.
  17. Falchook G, Coleman RL, Roszak A, et al. Alisertib in Combination with Weekly Paclitaxel in Patients with Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial. JAMA Oncol. 2018:e183773. PMID: 30347019.
  18. Feldman G, Kappes D, Mookerjee-Basu J, Freeman T, Fertala A, Parvizi J. Novel Mutation in Teneurin 3 Found to Co-Segregate in All Affecteds in a Multi-Generation Family with Developmental Dysplasia of the Hip. J Orthop Res. 2018. PMID: 30273960.
  19. Feofanov AV, Andreeva TV, Studitsky VM, Kirpichnikov MP. Reversibility of Structural Rearrangements in Mononucleosomes Induced by Ionic Strength. Moscow University Biological Sciences Bulletin. 2018;73(3):157-161.
  20. Gadgeel SM, Stevenson JP, Langer CJ, et al. Pembrolizumab and Platinum-Based Chemotherapy as First-Line Therapy for Advanced Non–Small-Cell Lung Cancer: Phase 1 Cohorts from the KEYNOTE-021 Study. Lung Cancer. 2018;125:273-281. PMID: 30429032.
  21. Ge Y, Borne E, Stewart S, et al. Simulations of the Regulatory Act Domain of Human Phenylalanine Hydroxylase Unveil Its Mechanism of Phenylalanine Binding. J Biol Chem. 2018. PMID: 30287685.
  22. Gershman B, Bukavina L, Chen Z, et al. The Association of Robot-Assisted Versus Pure Laparoscopic Radical Nephrectomy with Perioperative Outcomes and Hospital Costs. Eur Urol Focus. 2018. PMID: 30361146.
  23. Ghatalia P, Koenigsberg R, Pisarcik D, Handorf EA, Geynisman DM, Zibelman M. The Evolution of Clinical Trials in Renal Cell Carcinoma: A Status Report for 2013-2016 from the Clinicaltrials.Gov Website. Kidney Cancer. 2017;1(2):151-159. PMID: 30334017. PMC6179107.
  24. Ghatalia P, Rathmell WK. Systematic Review: Clearcode 34 – a Validated Prognostic Signature in Clear Cell Renal Cell Carcinoma (ccRCC). Kidney Cancer. 2018;2(1):23-29. PMID: 30320241. PMC6176730. NIHMS935715..
  25. Greco F, Autorino R, Altieri V, et al. Ischemia Techniques in Nephron-Sparing Surgery: A Systematic Review and Meta-Analysis of Surgical, Oncological, and Functional Outcomes. Eur Urol. 2018. PMID: 30327272.
  26. Haas NB, Uzzo RG. Perioperative Therapy in Renal Cell Carcinoma: What Do We Know, What Have We Learned, What’s Next? J Clin Oncol. 2018:Jco2018789131. PMID: 30372398. .
  27. Haifler M, Ristau BT, Higgins AM, et al. External Validation of Contact Surface Area as a Predictor of Postoperative Renal Function in Patients Undergoing Partial Nephrectomy. Journal of Urology. 2018;199(3):649-654. PMID: 28941921.
  28. Herman AB, Autieri MV. Cardiovascular Disease, Inflammation, and MRNA Stability. Aging (Albany NY). 2018;10(11):3046-3047. PMID: 30365397.
  29. Hota P, Dass C, Erkmen C, Donuru A, Kumaran M. Poststernotomy Complications: A Multimodal Review of Normal and Abnormal Postoperative Imaging Findings. AJR: Am J Roentgenol. 2018;211(6):1-12. PMID: 30300004.
  30. Johnson C, Drummer Ct, Virtue A, et al. Increased Expression of Resistin in MicroRNA-155-Deficient White Adipose Tissues May Be a Possible Driver of Metabolically Healthy Obesity Transition to Classical Obesity. Front Physiol. 2018;9:1297. PMID: 30369883. PMC6194169.
  31. Jung K, Park JC, Kang H, Brandes JC. Androgen Deprivation Therapy Is Associated with Decreased Second Primary Lung Cancer Risk in the United States Veterans with Prostate Cancer. Epidemiol Health. 2018;40:e2018040. PMID: 30121970. PMC6232654.
  32. Kalemkerian GP, Loo BW, Jr., Akerley W, et al. Nccn Guidelines Insights: Small Cell Lung Cancer, Version 2.2018. J Natl Compr Canc Netw. 2018;16(10):1171-1182. PMID: 30323087.
  33. Kasimova MA, Yazici AT, Yudin Y, et al. A Hypothetical Molecular Mechanism for Trpv1 Activation That Invokes Rotation of an S6 Asparagine. J Gen Physiol. 2018;150(11):1554-1566. PMID: 30333107. PMC6219692.
  34. Kaur A, Ecker BL, Douglass SM, et al. Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility. Cancer Discov. 2018. PMID: 30279173.
  35. Kozlova AL, Valieva ME, Maluchenko NV, Studitsky VM. [HMGB Proteins as DNA Chaperones That Modulate Chromatin Activity]. Mol Biol (Mosk). 2018;52(5):737-749. PMID: 30363049.
  36. Kupfer SS, Lubner S, Coronel E, et al. Adherence to Postresection Colorectal Cancer Surveillance at National Cancer Institute-Designated Comprehensive Cancer Centers. Cancer Med. 2018;7(11):5351-5358. PMID: 30338661. PMC6247039.
  37. Liao L, Liu ZZ, Langbein L, et al. Multiple Tumor Suppressors Regulate a HIF-Dependent Negative Feedback Loop via ISGF3 in Human Clear Cell Renal Cancer. Elife. 2018;7. PMID: 30355451. PMC6234029.
  38. Liu Z, Chen M, Xie LK, et al. CLCA4 Inhibits Cell Proliferation and Invasion of Hepatocellular Carcinoma by Suppressing Epithelial-Mesenchymal Transition via PI3K/AKT Signaling. Aging (Albany NY). 2018;10(10):2570-2584. PMID: 30312171. PMC6224236.
  39. Localio AR, Stack CB, Meibohm AR, et al. Inappropriate Statistical Analysis and Reporting in Medical Research: Perverse Incentives and Institutional Solutions. Ann Intern Med. 2018;169(8):577-578. PMID: 30304363.
  40. Mazor AM, Mateo AM, Demora L, et al. Breast Conservation Versus Mastectomy in Patients with T3 Breast Cancers (> 5 Cm): An Analysis of 37,268 Patients from the National Cancer Database. Breast Cancer Res Treat. 2018. PMID: 30343456.
  41. Mookerjee-Basu J, Hua X, Ge L, et al. Functional Conservation of a Developmental Switch in Mammals since the Jurassic Age. Mol Biol Evol. 2018. PMID: 30295892.
  42. Moore HCF, Unger JM, Phillips KA, et al. Final Analysis of the Prevention of Early Menopause Study (Poems)/Swog Intergroup S0230. J Natl Cancer Inst. 2018. PMID: 30371800.
  43. Myers RE, Stello B, Daskalakis C, et al. Decision Support and Navigation to Increase Colorectal Cancer Screening among Hispanic Patients. Cancer Epidemiol Biomarkers Prev. 2018. PMID: 30333221.
  44. Necchi A, Pond GR, Moschini M, et al. Development of a Prediction Tool for Exclusive Locoregional Recurrence after Radical Cystectomy in Patients with Muscle-Invasive Bladder Cancer. Clin Genitourin Cancer. 2018. PMID: 30292628.
  45. Nieborowska-Skorska M, Maifrede S, Ye M, et al. Non-Nad-Like Parp1 Inhibitor Enhanced Synthetic Lethal Effect of Nad-Like Parp Inhibitors against Brca1-Deficient Leukemia. Leuk Lymphoma. 2018:1-4. PMID: 30277116.
  46. O’Neil PT, Machen AJ, Thompson JA, et al. Constructing Kinetically Controlled Denaturation Isotherms of Folded Proteins Using Denaturant-Pulse Chaperonin Binding. Methods Mol Biol. 2019;1873:293-304. PMID: 30341618. PMC6196737. NIHMS972764.
  47. Patel RS, Wen KY, Aggarwal R. Demographic Pattern and Hospitalization Outcomes of Depression among 2.1 Million Americans with Four Major Cancers in the United States. Med Sci (Basel). 2018;6(4). PMID: 30355962.
  48. Putatunda R, Zhang Y, Li F, Yang XF, Barbe MF, Hu W. Adult Neurogenic Deficits in HIV-1 Tg26 Transgenic Mice. J Neuroinflammation. 2018;15(1):287. PMID: 30314515. PMC6182864.
  49. Qian F, Wang S, Mitchell J, et al. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. J Natl Cancer Inst. 2018. PMID: 30312457.
  50. Qumseya BJ, Bartel MJ, Gendy S, Bain P, Qumseya A, Wolfsen H. High Rate of over-Staging of Barrett’s Neoplasia with Endoscopic Ultrasound: Systemic Review and Meta-Analysis. Dig Liver Dis. 2018;50(5):438-445. PMID: 29573963.
  51. Reese JB, Sorice K, Lepore SJ, Daly MB, Tulsky JA, Beach MC. Patient-Clinician Communication About Sexual Health in Breast Cancer: A Mixed-Methods Analysis of Clinic Dialogue. Patient Educ Couns. 2018. PMID: 30314828.
  52. Rice SR, Molitoris JK, Vyfhuis MAL, et al. Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients with Non-Small-Cell Lung Cancer at Diagnosis. Clin Lung Cancer. 2018. PMID: 30337268.
  53. Ristau BT, Smaldone MC. Performance Measurement and Quality Improvement Initiatives for Bladder Cancer Care. Curr Urol Rep. 2018;19(12):100. PMID: 30357590.
  54. Roach M, Moughan J, Lawton CAF, et al. Sequence of Hormonal Therapy and Radiotherapy Field Size in Unfavourable, Localised Prostate Cancer (NRG/RTOG 9413): Long-Term Results of a Randomised, Phase 3 Trial. Lancet Oncol. 2018;19(11):1504-1515. PMID: 30316827.
  55. Russell Localio A, Stack CB, Meibohm AR, et al. Inappropriate Statistical Analysis and Reporting in Medical Research: Perverse Incentives and Institutional Solutions. Ann Intern Med. 2018;169(8):577-578. PMID: 30304363.
  56. Schwartz LA, Henry-Moss D, Egleston B, et al. Preventative Health and Risk Behaviors among Adolescent Girls with and without Family Histories of Breast Cancer. J Adolesc Health. 2018. PMID: 30301677.
  57. Sha X, Hoffman B, Liebermann DA. Loss of Gadd45b Accelerates BCR-ABL-Driven CML. Oncotarget. 2018;9(70):33360-33367. PMID: 30279966. PMC6161793.
  58. Shaytan AK, Xiao H, Armeev GA, et al. Structural Interpretation of DNA-Protein Hydroxyl-Radical Footprinting Experiments with High Resolution Using Hydroid. Nat Protoc. 2018;13(11):2535-2556. PMID: 30341436.
  59. Stinchcombe TE, Fan W, Schild SE, et al. A Pooled Analysis of Individual Patient Data from National Clinical Trials Network Clinical Trials of Concurrent Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer in Elderly Patients Versus Younger Patients. Cancer. 2018. PMID: 30343497.
  60. Stout MC, Campbell PM. Raspecting the Oncogene: New Pathways to Therapeutic Advances. Biochem Pharmacol. 2018;158:217-228. PMID: 30352234.
  61. Su F, Myers VD, Knezevic T, et al. Bcl-2-Associated Athanogene 3 Protects the Heart from Ischemia/Reperfusion Injury. JCI Insight. 2016;1(19):e90931. PMID: 27882354. PMC5111510.
  62. Sun Z, Zheng L, Chen M, Klein ML, Paesani F, Wu X. Electron-Hole Theory of the Effect of Quantum Nuclei on the X-Ray Absorption Spectra of Liquid Water. Phys Rev Lett. 2018;121(13):137401. PMID: 30312094.
  63. Timmermans S, Yang A, Gardner M, et al. Does Patient-Centered Care Change Genital Surgery Decisions? The Strategic Use of Clinical Uncertainty in Disorders of Sex Development Clinics. J Health Soc Behav. 2018;59(4):22146518802460. PMID: 30303019.
  64. Twardowski PW, Tangen CM, Wu X, et al. Parallel (Randomized) Phase II Evaluation of Tivantinib (ARQ197) and Tivantinib in Combination with Erlotinib in Papillary Renal Cell Carcinoma: SWOG S1107. Kidney Cancer. 2017;1(2):123-132. PMID: 30334014. PMC6179121.
  65. Tyner JW, Tognon CE, Bottomly D, et al. Functional Genomic Landscape of Acute Myeloid Leukaemia. Nature. 2018;562(7728):526-531. PMID: 30333627. PMC6280667.
  66. Upshaw JN, O’Neill A, Carver JR, et al. Fluoropyrimidine Cardiotoxicity: Time for a Contemporaneous Appraisal. Clin Colorectal Cancer. 2018. PMID: 30348619.
  67. Wheeler DC, Jones RM, Schootman M, Nelson EJ. Explaining Variation in Elevated Blood Lead Levels among Children in Minnesota Using Neighborhood Socioeconomic Variables. Sci Total Environ. 2019;650(Pt 1):970-977. PMID: 30308871.
  68. Wiest DL. Gadd45 Stress Sensors in Suppression of Leukemia. Oncotarget. 2018;9(76):34191-34192. PMID: 30344933. PMC6188131.
  69. Zhang F, Tapera TM, Gou J. Application of a New Dietary Pattern Analysis Method in Nutritional Epidemiology. BMC Med Res Methodol. 2018;18(1):119. PMID: 30373530. PMC6206725.
  70. Zhang S, Taylor AK, Huang X, et al. Venous Thromboembolism Laboratory Testing (factor V Leiden and factor II C.*97G>A), 2018 Update: A Technical Standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2018. PMID: 30297698.

Staff Publications: August-September 2018

  1. Ackroyd SA, Brown J, Houck K, et al. A Preoperative Risk Score to Predict Red Blood Cell Transfusion in Patients Undergoing Hysterectomy for Ovarian Cancer. Am J Obstet Gynecol. 2018. PMID: 30240655.
  2. Bella R, Kaminski R, Mancuso P, et al. Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice. Mol Ther Nucleic Acids. 2018;12:275-282. PMID: 30195766. PMC6011019.
  3. Berry K, Elder D, Kroger L. The Evolving Role of the Medical Radiation Safety Officer. Health Phys. 2018;115(5):628-636. PMID: 30260854.
  4. Bevelacqua JJ, Mortazavi SMJ. Commentary: Immune System Dysregulation During Spaceflight: Potential Countermeasures for Deep Space Exploration Missions. Front Immunol. 2018;9:2024. PMID: 30233600. PMC6131484.
  5. Bodor JN, Kasireddy V, Borghaei H. First-Line Therapies for Metastatic Lung Adenocarcinoma without a Driver Mutation. J Oncol Pract. 2018;14(9):529-535. PMID: 30205771.
  6. Borgmann H, Cooperberg M, Murphy D, et al. Online Professionalism-2018 Update of European Association of Urology (@Uroweb) Recommendations on the Appropriate Use of Social Media. Eur Urol. 2018. PMID: 30177286.
  7. Boumber Y. Tumor Mutational Burden (TMB) as a Biomarker of Response to Immunotherapy in Small Cell Lung Cancer. J Thorac Dis. 2018;10(8):4689-4693. PMID: 30233840. PMC6129910.
  8. Bryan MS, Argos M, Andrulis IL, et al. Germline Variation and Breast Cancer Incidence: A Gene-Based Association Study and Whole-Genome Prediction of Early-Onset Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. 2018;27(9):1057-1064. PMID: 29898891 PMCID: PMC6125194.
  9. Bukavina L, Tilburt JC, Konety B, et al. Perceptions of Prostate MRI and Fusion Biopsy of Radiation Oncologists and Urologists for Patients Diagnosed with Prostate Cancer: Results from a National Survey. Eur Urol Focus. 2018. PMID: 30219709.
  10. Burton LJ, Hawsawi O, Loyd Q, et al. Association of Epithelial Mesenchymal Transition with Prostate and Breast Health Disparities. PLoS One. 2018;13(9):e0203855. PMID: 30199553. PMC6130866.
  11. Cheung JY, Gordon J, Wang J, et al. Mitochondrial Dysfunction in Human Immunodeficiency Virus-1 Transgenic Mouse Cardiac Myocytes. J Cell Physiol. 2018. PMID: 30256393.
  12. Doss M. Are We Approaching the End of the Lnt Model Era? J Nucl Med. 2018. PMID: 30262515.
  13. Doss M. Pediatric Computed Tomography Scans and Cancer Risk. JAMA Pediatr. 2018. PMID: 30193290.
  14. DuBay DA, Ivankova NV, Herby I, et al. A Quantitative Appraisal of African Americans’ Decisions to Become Registered Organ Donors at the Driver’s License Office. Clin Transplant. 2018:e13402. PMID: 30179271.
  15. Fakhry C, Nguyen-Tan PF, Lambert L, et al. In Regard to Bossi Et Al. Int J Radiat Oncol Biol Phys. 2018;102(3):669-670. PMID: 30238902. Letter.
  16. Flaig TW, Spiess PE, Agarwal N, et al. Nccn Guidelines Insights: Bladder Cancer, Version 5.2018. J Natl Compr Canc Netw. 2018;16(9):1041-1053. PMID: 30181416.
  17. Fragoso MF, Romualdo GR, Vanderveer LA, et al. Lyophilized Acai Pulp (Euterpe Oleracea Mart) Attenuates Colitis-Associated Colon Carcinogenesis While Its Main Anthocyanin Has the Potential to Affect the Motility of Colon Cancer Cells. Food Chem Toxicol. 2018;121:237-245. PMID: 30194994.
  18. Ghadimi-Moghadam A, Mortazavi SMJ, Hosseini-Moghadam A, et al. Does Exposure to Static Magnetic Fields Generated by Magnetic Resonance Imaging Scanners Raise Safety Problems for Personnel? Journal of Biomedical Physics and Engineering. 2018;8(3):333-336.
  19. Goel N, D’Souza JW, Ruth KJ, et al. The Utility of Preoperative Vascular Grading in Patients Undergoing Surgery First for Pancreatic Cancer: Does Radiologic Arterial or Venous Involvement Predict Pathologic Margin Status? J Oncol. 2018;2018:7675262. PMID: 30186324. PMC6110012.
  20. Hall MJ, Morris AM, Sun W. Precision Medicine Versus Population Medicine in Colon Cancer: From Prospects of Prevention, Adjuvant Chemotherapy, and Surveillance. Am Soc Clin Oncol Educ Book. 2018(38):220-230. PMID: 30231337.
  21. Handorf EA, Heckman CJ, Darlow S, Slifker M, Ritterband L. A Hierarchical Clustering Approach to Identify Repeated Enrollments in Web Survey Data. Plos One. 2018;13(9):e0204394. PMID: 30252908.
  22. Hedges SB, Tao Q, Walker M, Kumar S. Accurate Timetrees Require Accurate Calibrations. Proc Natl Acad Sci U S A. 2018. PMID: 30266795. Letter.
  23. Jin X, Daher SS, Lee M, Buttaro B, Andrade RB. Ribosome-Templated Azide-Alkyne Cycloadditions Using Resistant Bacteria as Reaction Vessels: In Cellulo Click Chemistry. ACS Med Chem Lett. 2018;9(9):907-911. PMID: 30258539. PMC6142060.
  24. Johnson M, Pennell NA, Borghaei H. “My Patient Was Diagnosed with Nontargetable Advanced Non-Small Cell Lung Cancer. What Now?” Diagnosis and Initial Treatment Options for Newly Diagnosed Patients with Advanced Nsclc. Am Soc Clin Oncol Educ Book. 2018(38):696-707. PMID: 30231362.
  25. Kishan AU, Wang X, Seiferheld W, et al. Association of Gleason Grade with Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-Analysis. JAMA Oncology. 2018.
  26. Kondrashova O, Topp M, Nesic K, et al. Methylation of All BRCA1 Copies Predicts Response to the PARP Inhibitor Rucaparib in Ovarian Carcinoma. Nat Commun. 2018;9(1):3970. PMID: 30266954. PMC6162272.
  27. Lee M, Hu D, Bunney G, et al. Health Behavior Practice among Understudied Chinese and Filipino Americans with Cardiometabolic Diseases. Prev Med Rep. 2018;11:240-246. PMID: 30210996. PMC6129966.
  28. Mani S, Ghosh J, Lan Y, et al. Epigenetic Changes in Reterm Birth Placenta Suggest a Role for Adamts Genes in Spontaneous Preterm Birth. Hum Mol Genet. 2018. PMID: 30239759.
  29. Manne SL, Kashy DA, Kissane DW, Ozga M, Virtue SM, Heckman CJ. The Course and Predictors of Perceived Unsupportive Responses by Family and Friends among Women Newly Diagnosed with Gynecological Cancers. Transl Behav Med. 2018. PMID: 30189025.
  30. Martin JM, Goldstein LJ. Profile of Abemaciclib and Its Potential in the Treatment of Breast Cancer. Onco Targets Ther. 2018;11:5253-5259. PMID: 30214230. PMC6120573.
  31. Mitchell TC, Hamid O, Smith DC, et al. Epacadostat Plus Pembrolizumab in Patients with Advanced Solid Tumors: Phase I Results from a Multicenter, Open-Label Phase I/Ii Trial (Echo-202/Keynote-037). J Clin Oncol. 2018:Jco2018789602. PMID: 30265610.
  32. Moten AS, Zhao H, Wu H, Farma JM. Malignant Granular Cell Tumor: Clinical Features and Long-Term Survival. J Surg Oncol. 2018. PMID: 30196562.
  33. Nacson J, Krais JJ, Bernhardy AJ, et al. Brca1 Mutation-Specific Responses to 53bp1 Loss-Induced Homologous Recombination and Parp Inhibitor Resistance. Cell Rep. 2018;24(13):3513-3527.e3517. PMID: 30257212.
  34. Nicholas Bodor J, Kasireddy V, Borghaei H. First-Line Therapies for Metastatic Lung Adenocarcinoma without a Driver Mutation. Journal of Oncology Practice. 2018;14(9):529-535.
  35. Ogba N, Arwood NM, Bartlett NL, et al. Chimeric Antigen Receptor T-Cell Therapy. J Natl Compr Canc Netw. 2018;16(9):1092-1106. PMID: 30181421.
  36. Pakyz AL, Kohinke R, Opper P, Hohmann SF, Jones RM, Nadpara P. High-Risk Medication Use for Clostridium Difficile Infection among Hospitalized Patients with Cancer. Am J Infect Control. 2018. PMID: 30220616.
  37. Paliwal Y, Gendron TL, Jones RM, Moczygemba L, Nadpara PA, Slattum PW. A Qualitative Study to Understand over-the-Counter Medication Use and Decision-Making among Residents of Senior-Living Communities. Res Social Adm Pharm. 2018. PMID: 30253975.
  38. Radich JP, Deininger M, Abboud CN, et al. Chronic Myeloid Leukemia, Version 1.2019 Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2018;16(9):1108-1135. PMID: 30181422.
  39. Riddle DL, Slover JD, Ang DC, et al. Opioid Use Prior to Knee Arthroplasty in Patients Who Catastrophize About Their Pain: Preoperative Data from a Multisite Randomized Clinical Trial. J Pain Res. 2018;11:1549-1557. PMID: 30174454. PMC6109658.
  40. Ristau BT, Handorf EA, Cahn DB, Kutikov A, Uzzo RG, Smaldone MC. Partial Nephrectomy Is Not Associated with an Overall Survival Advantage over Radical Nephrectomy in Elderly Patients with Stage I and Ii Renal Masses: An Analysis of the National Cancer Database. Cancer. 2018. PMID: 30207380.
  41. Roberts ME, Aynardi JT, Chu CS. Uterine Leiomyosarcoma: A Review of the Literature and Update on Management Options. Gynecol Oncol. 2018. PMID: 30244960.
  42. Rudolph MJ, Vance DJ, Kelow S, et al. Contribution of an Unusual Cdr2 Element of a Single Domain Antibody in Ricin Toxin Binding Affinity and Neutralizing Activity. Protein Eng Des Sel. 2018. PMID: 30265352.
  43. Singh T, Lee EH, Hartman TR, Ruiz-Whalen DM, O’Reilly AM. Opposing Action of Hedgehog and Insulin Signaling Balances Proliferation and Autophagy to Determine Follicle Stem Cell Lifespan. Dev Cell. 2018;46(6):720-734.e726. PMID: 30197240. PMC6159899. NIHMS1504158.
  44. Thenuwara AC, Cerkez EB, Shumlas SL, et al. Nickel Confined in the Interlayer Region of Birnessite: An Active Electrocatalyst for Water Oxidation. Angew Chem Int Ed Engl. 2016;55(35):10381-10385. PMID: 27151204.
  45. Tong CMC, Lucas J, Shah A, Foote C, Simhan J. Author Reply to Editorial Comment on “Novel Multimodal Analgesia Protocol Significantly Decreases Opioid Requirements in Inflatable Penile Prosthesis Patients”. Journal of Sexual Medicine. 2018;15(9):1364-1365. PMID: 30224023.
  46. Ward WH, Fluke LM, McEvoy CS, Fitch JL, Ricca RL. An Examination of Military General Surgeon Comfort with Complex Hepatopancreatobiliary Procedures. American Surgeon. 2018;84(8):E343-E345. PMID: 30185350.
  47. Wheeler DC, Jones RM, Schootman M, Nelson EJ. Explaining Variation in Elevated Blood Lead Levels among Children in Minnesota Using Neighborhood Socioeconomic Variables. Science of the Total Environment. 2019;650:970-977.
  48. Winkfield KM, Phillips JK, Joffe S, Halpern MT, Wollins DS, Moy B. Addressing Financial Barriers to Patient Participation in Clinical Trials: Asco Policy Statement. J Clin Oncol. 2018:Jco1801132. PMID: 30212297.
  49. Wu S, Luo Y, Viswanathan U, et al. Cpams Induce Assembly of Hbv Capsids with Altered Electrophoresis Mobility: Implications for Mechanism of Inhibiting Pgrna Packaging. Antiviral Res. 2018;159:1-12. PMID: 30201396.
  50. Zhang Y, Arango G, Li F, et al. Comprehensive Off-Target Analysis of Dcas9-Sam-Mediated Hiv Reactivation Via Long Noncoding Rna and Mrna Profiling. BMC Med Genomics. 2018;11(1):78. PMID: 30200981. PMC6131778.
  51. Zuniga SA, Lango MN. Effect of Rural and Urban Geography on Larynx Cancer Incidence and Survival. Laryngoscope. 2018;128(8):1874-1880. PMID: 29238975.

Staff Publications: July 2018

It’s been a busy month here at Talbot Library — literature searches, journal renewals, database renewals. In the spirit of better late than never, we give you the staff publications list for July 2018.

  1. Bartel MJ, Srivastava A, Pohl H. Response. Gastrointest Endosc. 2018;88(1):201. PMID: 29935617.
  2. Bartel MJ, Tokar JL. Non-Lifting Colorectal Neoplasia – Shall We Cast It Away? Endoscopy. 2018;50(1):6-7. PMID: 29268294.
  3. Benson AB, 3rd, Venook AP, Al-Hawary MM, et al. Anal Carcinoma, Version 2.2018, Nccn Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(7):852-871. PMID: 30006428.
  4. Benson AB, 3rd, Venook AP, Al-Hawary MM, et al. Rectal Cancer, Version 2.2018, Nccn Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(7):874-901. PMID: 30006429.
  5. Bleicher RJ. Timing and Delays in Breast Cancer Evaluation and Treatment. Ann Surg Oncol. 2018;25(10):2829-2838. PMID: 29968031. PMC6123282.
  6. Bretthauer M, Kalager M, Weinberg DS. From Colorectal Cancer Screening Guidelines to Headlines: Beware! Ann Intern Med. 2018;169(6):405-406. PMID: 29987330.
  7. Burger RA, Deng W, Makker V, et al. Phase Ii Evaluation of Dalantercept in the Treatment of Persistent or Recurrent Epithelial Ovarian Cancer: An Nrg Oncology/Gynecologic Oncology Group Study. Gynecol Oncol. 2018;150(3):466-470. PMID: 30041929.
  8. Chang WL, Jackson C, Riel S, et al. Differential Preventive Activity of Sulindac and Atorvastatin in Apc(+/Min-Fccc)Mice with or without Colorectal Adenomas. Gut. 2018;67(7):1290-1298. PMID: 29122850. PMC6031273.
  9. Dampier W, Sullivan NT, Mell JC, et al. Broad-Spectrum and Personalized Guide Rnas for Crispr/Cas9 Hiv-1 Therapeutics. AIDS Res Hum Retroviruses. 2018. PMID: 29968495.
  10. Demark-Wahnefried W, Schmitz KH, Alfano CM, et al. Weight Management and Physical Activity Throughout the Cancer Care Continuum. CA Cancer J Clin. 2018;68(1):64-89. PMID: 29165798. PMC5766382.
  11. Diefenbach MA, Benedict C, Miller SM, et al. Examining the Impact of a Multimedia Intervention on Treatment Decision-Making among Newly Diagnosed Prostate Cancer Patients: Results from a Nationwide Rct. Transl Behav Med. 2018. PMID: 29982747.
  12. Doss M. Radiation Dose from Cardiac Catheterization Procedures in Young Patients May Not Contribute to Increased Cancer Risk. Eur J Epidemiol. 2018;33(4):425-426. PMID: 29616389.
  13. Ettinger DS, Aisner DL, Wood DE, et al. Nccn Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018. J Natl Compr Canc Netw. 2018;16(7):807-821. PMID: 30006423.
  14. Fareed MM, DeMora L, Esnaola NF, et al. Concurrent Chemoradiation for Resected Gall Bladder Cancers and Cholangiocarcinomas. J Gastrointest Oncol. 2018;9(4):762-768. PMID: 30151273. PMC6087856.
  15. Gangolli RA, Devlin SM, Gerstenhaber JA, Lelkes PI, Yang M. A Bilayered Poly (Lactic-Co-Glycolic Acid) Scaffold Provides Differential Cues for the Differentiation of Dental Pulp Stem Cells. Tissue Eng Part A. 2018. PMID: 29984629.
  16. Guo Y, Chu X, Parrott NJ, et al. Advancing Predictions of Tissue and Intracellular Drug Concentrations Using in Vitro, Imaging and Physiologically Based Pharmacokinetic Modeling Approaches. Clin Pharmacol Ther. 2018. PMID: 30059145.
  17. Gupta S, Kelow S, Wang L, Andrake MD, Dunbrack RL, Jr., Kruger WD. Mouse Modeling and Structural Analysis of the P.G307s Mutation in Human Cystathionine Beta-Synthase (Cbs) Reveal Effects on Cbs Activity but Not Stability. J Biol Chem. 2018;293(36):13921-13931. PMID: 30030379. PMC6130948.
  18. Gurova K, Chang HW, Valieva ME, Sandlesh P, Studitsky VM. Structure and Function of the Histone Chaperone Fact – Resolving Factual Issues. Biochim Biophys Acta Gene Regul Mech. 2018. PMID: 30055319.
  19. He P, Zhang BW, Arasteh S, Wang L, Abel R, Levy RM. Conformational Free Energy Changes Via an Alchemical Path without Reaction Coordinates. J Phys Chem Lett. 2018;9(15):4428-4435. PMID: 30024165. PMC6092130.
  20. Ingram JP, Tursi S, Zhang T, et al. A Nonpyroptotic Ifn-Gamma-Triggered Cell Death Mechanism in Nonphagocytic Cells Promotes Salmonella Clearance in Vivo. J Immunol. 2018;200(10):3626-3634. PMID: 29654208. PMC6034694.
  21. Jelinek J, Lee JT, Cesaroni M, et al. Digital Restriction Enzyme Analysis of Methylation (Dream). Methods Mol Biol. 2018;1708:247-265. PMID: 29224148.
  22. Kaminski R, Chen Y, Salkind J, et al. Negative Feedback Regulation of Hiv-1 by Gene Editing Strategy. Sci Rep. 2016;6:31527. PMID: 27528385. PMC4985742.
  23. Karakasheva TA, Lin EW, Tang Q, et al. Il-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment. Cancer Res. 2018;78(17):4957-4970. PMID: 29976575. PMC6125177.
  24. Kasireddy V, Martin J, Rubin RN. A 65-Year-Old Man with Cancer and a New Acute Dvt. Consultant. 2018;58(7):182-184.
  25. Khatri NV, Patel B, Kohli DR, Solomon SS, Bull-Henry K, Kessler CM. Lenalidomide as a Novel Therapy for Gastrointestinal Angiodysplasia in Von Willebrand Disease. Haemophilia. 2018;24(2):278-282. PMID: 29446520.
  26. Kim AH, Konety B, Chen Z, et al. Comparative Effectiveness of Local and Systemic Therapy for T4 Prostate Cancer. Urology. 2018. PMID: 29990574.
  27. Lee HO, Wang L, Kuo YM, Andrews AJ, Gupta S, Kruger WD. S-Adenosylhomocysteine Hydrolase over-Expression Does Not Alter S-Adenosylmethionine or S-Adenosylhomocysteine Levels in Cbs Deficient Mice. Mol Genet Metab Rep. 2018;15:15-21. PMID: 30023284. PMC6047060.
  28. Lee Z, Uzzo R, Asghar A, et al. Functional Parenchymal Volume-Based Spectrum Score Is Able to Quantify Ischemic Injury after Partial Nephrectomy. Urology. 2018. PMID: 30063909.
  29. Lheureux S, Butler MO, Clarke B, et al. Association of Ipilimumab with Safety and Antitumor Activity in Women with Metastatic or Recurrent Human Papillomavirus-Related Cervical Carcinoma. JAMA Oncol. 2018;4(7):e173776. PMID: 29145543. PMC6145732.
  30. Li Q, Damish A, Frazier ZJ, et al. Ercc2 Helicase Domain Mutations Confer Nucleotide Excision Repair Deficiency and Drive Cisplatin Sensitivity in Muscle-Invasive Bladder Cancer. Clin Cancer Res. 2018. PMID: 29980530.
  31. Lu Y, Beeghly-Fadiel A, Wu L, et al. A Transcriptome-Wide Association Study among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res. 2018;78(18):5419-5430. PMID: 30054336. PMC6139053.
  32. Luo X, Jhala N, Khurana JS, Fundakowski C, Jhala DN, Wang H. Moving toward a Systematic Approach for Reporting Salivary Gland Cytopathology: An Institutional Experience and Literature Review. Arch Pathol Lab Med. 2018. PMID: 30044125.
  33. Lupey-Green LN, Caruso LB, Madzo J, et al. Parp1 Stabilizes Ctcf Binding and Chromatin Structure to Maintain Epstein-Barr Virus Latency Type. J Virol. 2018;92(18). PMID: 29976663. PMC6146685.
  34. Makhov P, Joshi S, Ghatalia P, Kutikov A, Uzzo RG, Kolenko VM. Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies. Mol Cancer Ther. 2018;17(7):1355-1364. PMID: 29967214. PMC6034114. NIHMS967458.
  35. Merzianu M, Groman A, Hutson A, et al. Trends in Bone Marrow Sampling and Core Biopsy Specimen Adequacy in the United States and Canada: A Multicenter Study. Am J Clin Pathol. 2018;150(5):393-405. PMID: 30052721. PMC6166687.
  36. Miller KD, O’Neill A, Gradishar W, et al. Double-Blind Phase Iii Trial of Adjuvant Chemotherapy with and without Bevacizumab in Patients with Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer (E5103). J Clin Oncol. 2018;36(25):2621-2629. PMID: 30040523. PMC6118403.
  37. Moore KN, Bendell JC, LoRusso PM, et al. First-in-Human Study of the Anti-Hb-Egf Antibody U3-1565 in Subjects with Advanced Solid Tumors. Invest New Drugs. 2018. PMID: 30056611.
  38. Mortazavi SMJ, Rangacharyulu C, Bevelacqua JJ, Welsh J, Waligorski M, Doss M. Comments on “the Past Informs the Future: An Overview of the Million Worker Study and the Mallinckrodt Chemical Works Cohort”. Health Phys. 2018;115(3):387-388. PMID: 30045120.
  39. Nakagawa M, Shaffer AL, 3rd, Ceribelli M, et al. Targeting the Htlv-I-Regulated Batf3/Irf4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma. Cancer Cell. 2018;34(2):286-297 e210. PMID: 30057145.
  40. Novosel E, Borchers K, Kluger PJ, et al. New Approaches to Respiratory Assist: Bioengineering an Ambulatory, Miniaturized Bioartificial Lung. Asaio j. 2018. PMID: 30044238.
  41. Pang M, Bartel MJ, Clayton DB, Brahmbhatt B, Woodward TA. Selective Application of Fully Covered Biliary Stents and Narrow-Diameter Esophageal Stents for Proximal Esophageal Indications. Endoscopy. 2018. PMID: 30005444.
  42. Ristau BT, Kutikov A. Editorial Comment. J Urol. 2018;199(3):639-640. PMID: 29227811.
  43. Ruggieri DG, Bass SB, Alhajji M, Gordon TF. Understanding Parents’ Perceptions of School-Based Bmi Screening and Bmi Report Cards Using Perceptual Mapping: Implications for School Nurses. J Sch Nurs. 2018:1059840518789243. PMID: 30033842.
  44. Scilla KA, Zandberg DP, Bentzen SM, et al. Case-Control Study of Pd-1, Pd-L1 and B7-H3 Expression in Lung Cancer Patients with and without Human Immunodeficiency Virus (Hiv) Infection. Lung Cancer. 2018;123:87-90. PMID: 30089601.
  45. Smith EP, Li H, Friedberg JW, et al. Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A Swog and Blood and Marrow Transplant Clinical Trials Network Phase Ii Trial (Swog S0410/Bmt Ctn 0703). Biol Blood Marrow Transplant. 2018;24(4):700-707. PMID: 29289757. PMC5965270.
  46. Sonpavde GP, Mariani L, LoVullo S, et al. Impact of the Number of Cycles of Platinum Based First Line Chemotherapy of Advanced Urothelial Carcinoma. J Urol. 2018. PMID: 30012366.
  47. Sparano J, O’Neill A, Alpaugh K, et al. Association of Circulating Tumor Cells with Late Recurrence of Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol. 2018. PMID: 30054636.
  48. Stepanova DS, Braun L, Chernoff J. A New Concept in Nf2 Pharmacotherapy: Targeting Fatty Acid Synthesis. Oncoscience. 2018;5(5-6):126-127. PMID: 30035161. PMC6049319.
  49. Tan CRC, Barta SK, Lee J, Rudek MA, Sparano JA, Noy A. Combination Antiretroviral Therapy Accelerates Immune Recovery in Patients with Hiv-Related Lymphoma Treated with Epoch: A Comparison within One Prospective Trial Amc034. Leuk Lymphoma. 2018;59(8):1851-1860. PMID: 29160731. PMC5962410.
  50. Tong CMC, Lucas J, Shah A, Foote C, Simhan J. Novel Multi-Modal Analgesia Protocol Significantly Decreases Opioid Requirements in Inflatable Penile Prosthesis Patients. J Sex Med. 2018;15(8):1187-1194. PMID: 30017719.
  51. Wang Y, Yang E, Wells MM, et al. Propofol Inhibits the Voltage-Gated Sodium Channel Nachbac at Multiple Sites. J Gen Physiol. 2018;150(9):1317-1331. PMID: 30018039. PMC6122922.
  52. Ward WH, Goel N, Ruth KJ, et al. Predictive Value of Leukocyte- and Platelet-Derived Ratios in Rectal Adenocarcinoma. Journal of Surgical Research. 2018;232:275-282.
  53. Wei S, Ehya H. Degenerated Keratinized Tumor Cells in Oropharyngeal Human Papilloma Virus-Associated Squamous Cell Carcinoma: A Pitfall in P16 Immunostaining of Fine-Needle Aspiration Specimens. Acta Cytol. 2018:1-7. PMID: 29966127.
  54. Yang X, Yue R, Zhang J, et al. Gastrin Protects against Myocardial Ischemia/Reperfusion Injury Via Activation of Risk (Reperfusion Injury Salvage Kinase) and Safe (Survivor Activating Factor Enhancement) Pathways. J Am Heart Assoc. 2018;7(14). PMID: 30005556. PMC6064830.
  55. Zaorsky NG, Lehrer EJ, Handorf E, Meyer JE. Dose Escalation in Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Meta-Analysis. Am J Clin Oncol. 2018. PMID: 29965809.
  56. Zhang B, Jiao A, Dai M, Wiest DL, Zhuang Y. Id3 Restricts Gammadelta Nkt Cell Expansion by Controlling Egr2 and C-Myc Activity. J Immunol. 2018;201(5):1452-1459. PMID: 30012846. PMC6103809.

 

Staff Publications: June 2018

  1. Bartel MJ, Srivastava A, Pohl H. Response. Gastrointest Endosc. 2018;88(1):201. PMID: 29935617.
  2. Battistuzzi FU, Tao Q, Jones L, Tamura K, Kumar S. Reltime Relaxes the Strict Molecular Clock Throughout the Phylogeny. Genome Biol Evol. 2018;10(6):1631-1636. PMID: 29878203. PMC6022624.
  3. Beatty A, Fink LS, Singh T, et al. Metabolite Profiling Reveals the Glutathione Biosynthetic Pathway as a Therapeutic Target in Triple-Negative Breast Cancer. Mol Cancer Ther. 2018;17(1):264-275. PMID: 29021292. PMC5892195.
  4. Beaufay C, Ledoux A, Jansen O, et al. In Vivo Antimalarial and Antitrypanosomal Activity of Strychnogucine B, a Bisindole Alkaloid from Strychnos Icaja. Planta Med. 2018;84(12-13):881-885. PMID: 29929205.
  5. Bichakjian CK, Olencki T, Aasi SZ, et al. Merkel Cell Carcinoma, Version 1.2018, Nccn Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(6):742-774. PMID: 29891526.
  6. Cagney DN, Martin AM, Catalano PJ, et al. Impact of Pemetrexed on Intracranial Disease Control and Radiation Necrosis in Patients with Brain Metastases from Non-Small Cell Lung Cancer Receiving Stereotactic Radiation. Radiother Oncol. 2018;126(3):511-518. PMID: 29398153.
  7. Cahn DB, Handorf EA, Smaldone MC. Bladder Extirpation Vs Preservation: The Treatment Debate. JAMA Surg. 2018. PMID: 29955758.
  8. Carqueijeiro I, Brown S, Chung K, et al. Two Tabersonine 6,7-Epoxidases Initiate Lochnericine-Derived Alkaloid Biosynthesis in Catharanthus Roseus. Plant Physiol. 2018;177(4):1473-1486. PMID: 29934299. PMC6084683.
  9. Chhatre S, Jefferson A, Cook R, et al. Patient-Centered Recruitment and Retention for a Randomized Controlled Study. Trials. 2018;19(1):205. PMID: 29587805. PMC5870194.
  10. Doss M. Letter by Doss Regarding Article, “Radiation-Induced DNA Damage in Operators Performing Endovascular Aortic Repair”. Circulation. 2018;137(24):2678-2679. PMID: 29891633.
  11. Drilon A, Laetsch TW, Kummar S, et al. Efficacy of Larotrectinib in Trk Fusion-Positive Cancers in Adults and Children. N Engl J Med. 2018;378(8):731-739. PMID: 29466156. PMC5857389.
  12. Engel N. Sex Differences in Early Embryogenesis: Inter-Chromosomal Regulation Sets the Stage for Sex-Biased Gene Networks: The Dialogue between the Sex Chromosomes and Autosomes Imposes Sexual Identity Soon after Fertilization. Bioessays. 2018;40(9):e1800073. PMID: 29943439.
  13. Ferris RL, Nikiforov Y, Terris D, et al. Ahns Series: Do You Know Your Guidelines? Ahns Endocrine Section Consensus Statement: State-of-the-Art Thyroid Surgical Recommendations in the Era of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features. Head Neck. 2018;40(9):1881-1888. PMID: 29947030.
  14. Garriga J, Laumet G, Chen SR, et al. Nerve Injury-Induced Chronic Pain Is Associated with Persistent DNA Methylation Reprogramming in Dorsal Root Ganglion. J Neurosci. 2018;38(27):6090-6101. PMID: 29875269. PMC6031579.
  15. Goel N, Manstein SM, Ward WH, et al. Does the Surgical Apgar Score Predict Serious Complications after Elective Major Cancer Surgery? J Surg Res. 2018;231:242-247. PMID: 30278936.
  16. Golemis EA, Scheet P, Beck TN, et al. Molecular Mechanisms of the Preventable Causes of Cancer in the United States. Genes Dev. 2018;32(13-14):868-902. PMID: 29945886. PMC6075032.
  17. Good CR, Panjarian S, Kelly AD, et al. Tet1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer. Cancer Res. 2018;78(15):4126-4137. PMID: 29891505. PMC6072603.
  18. Haifler M, Ristau BT, Higgins AM, et al. External Validation of Contact Surface Area as a Predictor of Postoperative Renal Function in Patients Undergoing Partial Nephrectomy. J Urol. 2018;199(3):649-654. PMID: 28941921.
  19. Hayakawa K, Formica AM, Nakao Y, et al. Early Generated B-1-Derived B Cells Have the Capacity to Progress to Become Mantle Cell Lymphoma-Like Neoplasia in Aged Mice. J Immunol. 2018;201(2):804-813. PMID: 29898964. PMC6036230.
  20. Horwitz SM, Ansell SM, Ai WZ, et al. NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018. J Natl Compr Canc Netw. 2018;16(2):123-135. PMID: 29439173.
  21. Janapati S, Wurtzel J, Dangelmaier C, et al. Tc21/Rras2 Regulates Glycoprotein Vi-Fcrgamma-Mediated Platelet Activation and Thrombus Stability. J Thromb Haemost. 2018. PMID: 29883056.
  22. Jordan SE, Micaily I, Hernandez E, et al. Image-Guided High-Dose-Rate Intracavitary Brachytherapy in the Treatment of Medically Inoperable Early-Stage Endometrioid Type Endometrial Adenocarcinoma. Brachytherapy. 2017;16(6):1144-1151. PMID: 28958736.
  23. Joshi SS, Handorf EA, Zibelman M, et al. Treatment Facility Volume and Survival in Patients with Metastatic Renal Cell Carcinoma: A Registry-Based Analysis. Eur Urol. 2018;74(3):387-393. PMID: 29880274.
  24. Kluetz PG, Kanapuru B, Lemery S, et al. Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an Fda and Critical Path Institute Workshop. Value Health. 2018;21(6):742-747. PMID: 29909880.
  25. Kumar S, Konikoff C, Sanderford M, et al. Flyexpress 7: An Integrated Discovery Platform to Study Coexpressed Genes Using in Situ Hybridization Images in Drosophila. G3 (Bethesda). 2017;7(8):2791-2797. PMID: 28667017. PMC5555482.
  26. Lamb EP, Pritchard FE, Nouer SS, et al. Understanding Disparities in Breast Cancer Care in Memphis, Tennessee. Am Surg. 2018;84(5):620-627. PMID: 29966559.
  27. Lamb EP, Shaw FR, Fleming MD. Investigation of the Diagnostic Precision and Utility of Sentinel Lymph Node Biopsy in the Treatment of Patients with Merkel Cell Carcinoma. Am Surg. 2018;84(5):e173-175. PMID: 29966556.
  28. Lepore SJ, Collins BN, Coffman DL, et al. Kids Safe and Smokefree (Kiss) Multilevel Intervention to Reduce Child Tobacco Smoke Exposure: Long-Term Results of a Randomized Controlled Trial. Int J Environ Res Public Health. 2018;15(6). PMID: 29895740. PMC6025102.
  29. Lewis-Wambi JS, Kim HR, Wambi C, et al. Correction To: Buthionine Sulfoximine Sensitizes Antihormone-Resistant Human Breast Cancer Cells to Estrogen-Induced Apoptosis. Breast Cancer Res. 2018;20(1):57. PMID: 29903038. PMC6003045.
  30. Lim C, Cohn JR, Cohn JA. Can a Diagnosis of Bladder Cancer Motivate Positive Lifestyle Changes-and Prevent Recurrent Disease? Transl Androl Urol. 2018;7(Suppl 2):S242-S245. PMID: 29928624. PMC5989117.
  31. Lubner S, Feng Y, Mulcahy M, et al. E4206: Amg 706 and Octreotide in Patients with Low-Grade Neuroendocrine Tumors. Oncologist. 2018;23(9):1006-e1104. PMID: 29853660.
  32. Lukka HR, Pugh SL, Bruner DW, et al. Patient Reported Outcomes in Nrg Oncology Rtog 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2018;102(2):287-295. PMID: 29913254.
  33. Masselli E, Carubbi C, Cambo B, et al. The -2518 a/G Polymorphism of the Monocyte Chemoattractant Protein-1 as a Candidate Genetic Predisposition Factor for Secondary Myelofibrosis and Biomarker of Disease Severity. Leukemia. 2018;32(10):2266-2270. PMID: 29568096.
  34. Miura S, Gomez K, Murillo O, et al. Predicting Clone Genotypes from Tumor Bulk Sequencing of Multiple Samples. Bioinformatics. 2018. PMID: 29931046.
  35. Myers VD, McClung JM, Wang J, et al. The Multifunctional Protein Bag3: A Novel Therapeutic Target in Cardiovascular Disease. JACC Basic Transl Sci. 2018;3(1):122-131. PMID: 29938246. PMC6013050. NIHMS949382.
    36. Nguyen JL, Heckman C, Perna F. Analysis of the Twitter “Don’t Fry Day” Campaign. JAMA Dermatol. 2018;154(8):961-962. PMID: 29926080. PMC6143026.
  36. Podszywalow-Bartnicka P, Maifrede S, Le BV, Nieborowska-Skorska M, Piwocka K, Skorski T. PARP1 Inhibitor Eliminated Imatinib-Refractory Chronic Myeloid Leukemia Cells in Bone Marrow Microenvironment Conditions. Leuk Lymphoma. 2018:1-3. PMID: 29932782.
  37. Pourfarhangi KE, De La Hoz EC, Cohen AR, Gligorijevic B. Contact Guidance Is Cell Cycle-Dependent. APL Bioeng. 2018;2(3). PMID: 29911682. PMC5997297. NIHMS971860.
  38. Prudnikova TY, Chernoff J. The Group I Pak Inhibitor Frax-1036 Sensitizes 11q13-Amplified Ovarian Cancer Cells to the Cytotoxic Effects of Rottlerin. Small GTPases. 2017;8(4):193-198. PMID: 27427770. PMC5680705.
  39. Punglia RS, Jiang W, Lipsitz SR, et al. Clinical Risk Score to Predict Likelihood of Recurrence after Ductal Carcinoma in Situ Treated with Breast-Conserving Surgery. Breast Cancer Res Treat. 2018;167(3):751-759. PMID: 29079937.
  40. Ralff MD, El-Deiry WS. Trail Pathway Targeting Therapeutics. Expert Review of Precision Medicine and Drug Development. 2018;3(3):197-204.
  41. Reichert M, Bakir B, Moreira L, et al. Regulation of Epithelial Plasticity Determines Metastatic Organotropism in Pancreatic Cancer. Dev Cell. 2018;45(6):696-711 e698. PMID: 29920275. PMC6011231. NIHMS974111.
  42. Sandler KA, Cook RR, Ciezki JP, et al. Clinical Outcomes for Patients with Gleason Score 10 Prostate Adenocarcinoma: Results from a Multi-Institutional Consortium Study. Int J Radiat Oncol Biol Phys. 2018;101(4):883-888. PMID: 29976500.
  43. Scannell Bryan M, Argos M, Andrulis IL, et al. Germline Variation and Breast Cancer Incidence: A Gene-Based Association Study and Whole-Genome Prediction of Early-Onset Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2018;27(9):1057-1064. PMID: 29898891. PMC6125194.
  44. Sementino E, Menges CW, Kadariya Y, et al. Inactivation of TP53 and PTEN Drives Rapid Development of Pleural and Peritoneal Malignant Mesotheliomas. J Cell Physiol. 2018;233(11):8952-8961. PMID: 29904909. PMC6168364.
  45. Shah MH, Goldner WS, Halfdanarson TR, et al. NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018. J Natl Compr Canc Netw. 2018;16(6):693-702. PMID: 29891520.
  46. Simons-Linares CR, Barkin JA, Wang Y, et al. Is There an Effect of Cannabis Consumption on Acute Pancreatitis? Dig Dis Sci. 2018. PMID: 29922897.
  47. Sullivan-Reed K, Bolton-Gillespie E, Dasgupta Y, et al. Simultaneous Targeting of Parp1 and Rad52 Triggers Dual Synthetic Lethality in Brca-Deficient Tumor Cells. Cell Rep. 2018;23(11):3127-3136. PMID: 29898385. PMC6082171.
  48. Tamura K, Tao Q, Kumar S. Theoretical Foundation of the RelTime Method for Estimating Divergence Times from Variable Evolutionary Rates. Mol Biol Evol. 2018;35(7):1770-1782. PMID: 29893954. PMC5995221.
  49. Virtue SM, Manne SL, Criswell K, Kissane D, Heckman CJ, Rotter D. Levels of Emotional Awareness During Psychotherapy among Gynecologic Cancer Patients. Palliat Support Care. 2018:1-8. PMID: 29880065.
  50. Wagner J, Kline CL, Zhou L, et al. Dose Intensification of Trail-Inducing ONC201 Inhibits Metastasis and Promotes Intratumoral NK Cell Recruitment. J Clin Invest. 2018;128(6):2325-2338. PMID: 29533922. PMC5983321.
  51. Walker EA. A Prospective Evaluation of Drug Discrimination in Pharmacology. Curr Top Behav Neurosci. 2018;39:319-328. PMID: 29959754.
  52. Warner WA, Lee TY, Fang F, et al. The Burden of Prostate Cancer in Trinidad and Tobago: One of the Highest Mortality Rates in the World. Cancer Causes Control. 2018;29(7):685-697. PMID: 29774450. PMC5999193.
  53. Winer A, Adams S, Mignatti P. Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures into Future Successes. Mol Cancer Ther. 2018;17(6):1147-1155. PMID: 29735645. PMC5984693.
  54. Wong E, Xu RH, Rubio D, et al. Migratory Dendritic Cells, Group 1 Innate Lymphoid Cells, and Inflammatory Monocytes Collaborate to Recruit NK Cells to the Virus-Infected Lymph Node. Cell Rep. 2018;24(1):142-154. PMID: 29972776.
  55. Wu L, Shi W, Long J, et al. A Transcriptome-Wide Association Study of 229,000 Women Identifies New Candidate Susceptibility Genes for Breast Cancer. Nat Genet. 2018;50(7):968-978. PMID: 29915430.
  56. Xiao C, Moughan J, Movsas B, et al. Risk Factors for Late Bowel and Bladder Toxicities in NRG Oncology Prostate Cancer Trials of High-Risk Patients: A Meta-Analysis of Physician-Rated Toxicities. Adv Radiat Oncol. 2018;3(3):405-411. PMID: 30202809. PMC6128023.
  57. Zeng H, Nanayakkara GK, Shao Y, et al. DNA Checkpoint and Repair Factors Are Nuclear Sensors for Intracellular Organelle Stresses-Inflammations and Cancers Can Have High Genomic Risks. Front Physiol. 2018;9:516. PMID: 29867559. PMC5958474.
  58. Zhang D, Wang B, Zhang G, Ma C, Deng X. Comparison of 3d and 2d Gamma Passing Rate Criteria for Detection Sensitivity to IMRT Delivery Errors. J Appl Clin Med Phys. 2018;19(4):230-238. PMID: 29905004. PMC6036388.
  59. Zhang Y, Xiang J, Han Y, et al. Initial Experience of Robot-Assisted Ivor-Lewis Esophagectomy: 61 Consecutive Cases from a Single Chinese Institution. Dis Esophagus. 2018. PMID: 29873693.

 

Staff Publications: May 2018

  1. Anari F, Ramamurthy C, Zibelman M. Impact of Tumor Microenvironment Composition on Therapeutic Responses and Clinical Outcomes in Cancer. Future Oncol. 2018;14(14):1409-1421. PMID: 29848096.
  2. Bauman J. Enhancing Communication between Oncology Care Providers and Patient Caregivers During Hospice. The Journal of Community and Supportive Oncology. 2018;16(2):e72-e80.
  3. Beck TN, Kharin LV, Kit OI, Dulaimi E, Boumber Y. Miliary Adenocarcinoma of the Lung Responds to Gefitinib and Afatinib. J Thorac Oncol. 2018;13(6):e95-e97. PMID: 29793652. Letter.
  4. Berry KE. Estimating Fluoroscopic Peak Skin Dose Using Manual Calculations. Health Phys. 2018;114(6):649-653. PMID: 29697515.
  5. Bertolo R, Autorino R, Simone G, et al. Outcomes of Robot-Assisted Partial Nephrectomy for Clinical T2 Renal Tumors: A Multicenter Analysis (Rosula Collaborative Group). Eur Urol. 2018;74(2):226-232. PMID: 29784191.
  6. Bevelacqua JJ, Mortazavi SMJ. Commentary: Human Pathophysiological Adaptations to the Space Environment. Front Physiol. 2017;8(JAN):1116. PMID: 29358922. PMC5766677.
  7. Blass BE, Iyer P, Abou-Gharbia M, et al. Design and Synthesis of Functionalized Piperazin-1yl-(E)-Stilbenes as Inhibitors of 17alpha-Hydroxylase-C17,20-Lyase (Cyp17). Bioorg Med Chem Lett. 2018;28(13):2270-2274. PMID: 29803730.
  8. Calvo E, Azaro A, Rodon J, et al. Hepatic Safety Analysis of Trabectedin: Results of a Pharmacokinetic Study with Trabectedin in Patients with Hepatic Impairment and Experience from a Phase 3 Clinical Trial. Invest New Drugs. 2018;36(3):476-486. PMID: 29177975.
  9. Churilla TM, Weiss SE. Emerging Trends in the Management of Brain Metastases from Non-Small Cell Lung Cancer. Curr Oncol Rep. 2018;20(7):54. PMID: 29736685.
  10. Colevas AD, Yom SS, Pfister DG, et al. Nccn Guidelines Insights: Head and Neck Cancers, Version 1.2018. J Natl Compr Canc Netw. 2018;16(5):479-490. PMID: 29752322.
  11. Cui D, Zhang BW, Matubayasi N, Levy RM. The Role of Interfacial Water in Protein-Ligand Binding: Insights from the Indirect Solvent Mediated Potential of Mean Force. J Chem Theory Comput. 2018;14(2):512-526. PMID: 29262255. PMC5897112. NIHMS955674.
  12. Cuttler JM, Mortazavi SMJ, Welsh JS, Doss M. Re: “Low-Dose Childhood Radiation Effects to the Thyroid Follow a Linear Dose-Response Trend and Persist Even 45+ Years after Exposure” (Clin Thyroidol 2017;29:235-236). Thyroid. 2018;28(5):679-680. PMID: 29132249. Letter.
  13. Di Meco A, Li JG, Barrero C, Merali S, Pratico D. Elevated Levels of Brain Homocysteine Directly Modulate the Pathological Phenotype of a Mouse Model of Tauopathy. Mol Psychiatry. 2018. PMID: 29728702.
  14. Doss M. Selective Focus on Rare Hematologic Malignancies Misleads Risk-Benefit Assessment of Radioiodine Therapy of Thyroid Cancer. J Clin Oncol. 2018;36(18):1883-1884. PMID: 29723093.
  15. Eilam-Frenkel B, Naaman H, Brkic G, et al. Microrna 146-5p, Mir-Let-7c-5p, Mir-221 and Mir-345-5p Are Differentially Expressed in Respiratory Syncytial Virus (Rsv) Persistently Infected Hep-2 Cells. Virus Res. 2018;251:34-39. PMID: 29733865.
  16. Fanale MA, Horwitz SM, Forero-Torres A, et al. Five-Year Outcomes for Frontline Brentuximab Vedotin with Chp for Cd30-Expressing Peripheral T-Cell Lymphomas. Blood. 2018;131(19):2120-2124. PMID: 29507077. PMC5946765.
  17. Feliciano JL, Le-Rademacher JG, Gajra A, et al. Do Older Patients with Non-Small Cell Lung Cancer Also Benefit from First-Line Platinum-Based Doublet Chemotherapy? Observations from a Pooled Analysis of 730 Prospectively-Treated Patients (Alliance Study A151622). J Geriatr Oncol. 2018;9(5):501-506. PMID: 29848457.
  18. Frost CJ, Andrulis IL, Buys SS, et al. Assessing Patient Readiness for Personalized Genomic Medicine. J Community Genet. 2018. PMID: 29804257.
  19. Fu X, Ju J, Lin Z, et al. Target Deletion of Complement Component 9 Attenuates Antibody-Mediated Hemolysis and Lipopolysaccharide (Lps)-Induced Acute Shock in Mice. Sci Rep. 2016;6:30239. PMID: 27444648. PMC4957234.
  20. Gabbasov R, Xiao F, Howe CG, et al. Nedd9 Promotes Oncogenic Signaling, a Stem/Mesenchymal Gene Signature, and Aggressive Ovarian Cancer Growth in Mice. Oncogene. 2018;37(35):4854-4870. PMID: 29773902. PMC6119087.
  21. Gerson JN, Ramamurthy C, Borghaei H. Managing Adverse Effects of Immunotherapy. Clin Adv Hematol Oncol. 2018;16(5):364-374. PMID: 29851932.
  22. Gettinger S, Hellmann MD, Chow LQM, et al. Nivolumab Plus Erlotinib in Patients with Egfr-Mutant Advanced Nsclc. J Thorac Oncol. 2018;13(9):1363-1372. PMID: 29802888.
  23. Giroux V, Stephan J, Chatterji P, et al. Mouse Intestinal Krt15+ Crypt Cells Are Radio-Resistant and Tumor Initiating. Stem Cell Reports. 2018;10(6):1947-1958. PMID: 29805107. PMC5993649.
  24. Goodwin RD, Cheslack-Postava K, Santoscoy S, et al. Trends in Cannabis and Cigarette Use among Parents with Children at Home: 2002 to 2015. Pediatrics. 2018;141(6). PMID: 29759986.
  25. Hernandez Borrero LJ, Sikder R, Lulla A, et al. Bcl-2 Protein Targeting by the P53/P21 Complex-Letter. Cancer Res. 2018;78(10):2770-2771. PMID: 29703721. Letter.
  26. Kapoor E, Benrubi D, Faubion SS. Menopausal Hormone Therapy in Gynecologic Cancer Survivors: A Review of the Evidence and Practice Recommendations. Clin Obstet Gynecol. 2018;61(3):488-495. PMID: 29762148.
  27. Koczwara B, Stover AM, Davies L, et al. Harnessing the Synergy between Improvement Science and Implementation Science in Cancer: A Call to Action. J Oncol Pract. 2018;14(6):335-340. PMID: 29750579. PMC6075851.
  28. Koh WJ, Abu-Rustum NR, Bean S, et al. Uterine Neoplasms, Version 1.2018, Nccn Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(2):170-199. PMID: 29439178.
  29. Kumar S, Stecher G, Li M, Knyaz C, Tamura K. Mega X: Molecular Evolutionary Genetics Analysis across Computing Platforms. Mol Biol Evol. 2018;35(6):1547-1549. PMID: 29722887. PMC5967553.
  30. Kumar SK, Callander NS, Alsina M, et al. NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018. J Natl Compr Canc Netw. 2018;16(1):11-20. PMID: 29295877.
  31. Lee MH, Chakhtoura M, Sriram U, Caricchio R, Gallucci S. Conventional Dcs from Male and Female Lupus-Prone B6.Nzm Sle1/Sle2/Sle3 Mice Express an Ifn Signature and Have a Higher Immunometabolism That Are Enhanced by Estrogen. J Immunol Res. 2018;2018:1601079. PMID: 29850618. PMC5925037.
  32. Li X, Wang L, Fang P, et al. Lysophospholipids Induce Innate Immune Transdifferentiation of Endothelial Cells, Resulting in Prolonged Endothelial Activation. J Biol Chem. 2018;293(28):11033-11045. PMID: 29769317. PMC6052225.
  33. Liang H, Zhou G, Ge Y, et al. Elucidating the Inhibition of Peptidoglycan Biosynthesis in Staphylococcus Aureus by Albocycline, a Macrolactone Isolated from Streptomyces Maizeus. Bioorg Med Chem. 2018;26(12):3453-3460. PMID: 29805074. PMC6008248.
  34. Lindsay T, Movva S. Role of Molecular Profiling in Soft Tissue Sarcoma. J Natl Compr Canc Netw. 2018;16(5):564-571. PMID: 29752329.
  35. Liu H, Kiseleva AA, Golemis EA. Ciliary Signalling in Cancer. Nat Rev Cancer. 2018;18(8):511-524. PMID: 29802351.
  36. Liu H, Sun Q, Sun Y, et al. Melk and Ezh2 Cooperate to Regulate Medulloblastoma Cancer Stem-Like Cell Proliferation and Differentiation. Mol Cancer Res. 2017;15(9):1275-1286. PMID: 28536141.
  37. Ma GX, Shive SE, Zhang G, et al. Evaluation of a Healthy Chinese Take-out Sodium-Reduction Initiative in Philadelphia Low-Income Communities and Neighborhoods. Public Health Rep. 2018;133(4):472-480. PMID: 29846132. PMC6055292.
  38. Maifrede S, Nieborowska-Skorska M, Sullivan-Reed K, et al. Tyrosine Kinase Inhibitor-Induced Defects in DNA Repair Sensitize Flt3(Itd)-Positive Leukemia Cells to Parp1 Inhibitors. Blood. 2018;132(1):67-77. PMID: 29784639. PMC6034642.
  39. Manne S, Kashy DA, Zaider T, et al. Interpersonal Processes and Intimacy among Men with Localized Prostate Cancer and Their Partners. J Fam Psychol. 2018;32(5):664-675. PMID: 29771551. PMC6072581.
  40. Mei L, Du W, Idowu M, von Mehren M, Boikos SA. Advances and Challenges on Management of Gastrointestinal Stromal Tumors. Front Oncol. 2018;8:135. PMID: 29868467. PMC5949718.
  41. Morrison C, Pabla S, Conroy JM, et al. Predicting Response to Checkpoint Inhibitors in Melanoma Beyond Pd-L1 and Mutational Burden. J Immunother Cancer. 2018;6(1):32. PMID: 29743104. PMC5944039.
  42. Mortazavi SMJ. Comment on ‘Domestic Light at Night and Breast Cancer Risk: A Prospective Analysis of 105 000 UK Women in the Generations Study’. Br J Cancer. 2018. PMID: 29769746. PMC5988714.
  43. Mortazavi SMJ. Comments on “Radiological Protection for Pregnant Women at a Large Academic Medical Cancer Center”. Phys Med. 2018;47:144. PMID: 29032028.
  44. Moten AS, Lango MN, Goel N, Goldberg AJ. Regional Diagnostic Rates, Treatments, and Outcomes among Patients with Invasive Ductal Carcinoma. J Surg Res. 2018;229:114-121. PMID: 29936977.
  45. Mukherjee S, Pantelopulos GA, Voelz VA. Markov Models of the Apo-Mdm2 Lid Region Reveal Diffuse yet Two-State Binding Dynamics and Receptor Poses for Computational Docking. Sci Rep. 2016;6:31631. PMID: 27538695. PMC4990920.
  46. Oliver JS, Allen RS, Eichorst MK, et al. A Pilot Study of Prostate Cancer Knowledge among African American Men and Their Health Care Advocates: Implications for Screening Decisions. Cancer Causes Control. 2018;29(7):699-706. PMID: 29804218.
  47. Pang M, Bartel MJ, Brand EC, et al. Outcome of Long Benign Esophageal Strictures Undergoing Endoscopictherapy: A Tertiary Center Experience. Dis Esophagus. 2018. PMID: 29718161.
  48. Patel NR, Piroyan A, Ganta S, et al. In Vitro and in Vivo Evaluation of a Novel Folate-Targeted Theranostic Nanoemulsion of Docetaxel for Imaging and Improved Anticancer Activity against Ovarian Cancers. Cancer Biol Ther. 2018;19(7):554-564. PMID: 29737910. PMC5989790.
  49. Patel R, Scheinfeldt LB, Sanderford MD, et al. Adaptive Landscape of Protein Variation in Human Exomes. Mol Biol Evol. 2018;35(8):2015-2025. PMID: 29846678. PMC6063297.
  50. Patel SA, Ng M, Nardello SM, Ruth K, Bleicher RJ. Immediate Breast Reconstruction for Women Having Inflammatory Breast Cancer in the United States. Cancer Med. 2018. PMID: 29761885. PMC6051180.
  51. Ristau BT, Manola J, Haas NB, et al. Retroperitoneal Lymphadenectomy for High Risk, Nonmetastatic Renal Cell Carcinoma: An Analysis of the Assure (Ecog-Acrin 2805) Adjuvant Trial. J Urol. 2018;199(1):53-59. PMID: 28728992. PMC5800986.
  52. Ristau BT, Smaldone MC. Editorial Comment. J Urol. 2018;199(4):914. PMID: 29287168.
  53. Santucci-Pereira J, Pogash TJ, Patel A, et al. Aspirin Abrogates Impairment of Mammary Gland Differentiation Induced by Early in Life Second-Hand Smoke in Mice. Carcinogenesis. 2018. PMID: 29788174. PMC6067120.
  54. Saxon B, Bass SB, Wright T, Panick J. Ebola and the Rhetoric of US Newspapers: Assessing Quality Risk Communication in Public Health Emergencies. Journal of Risk Research. 2018:1-14.
  55. Schuetze SM, Bolejack V, Thomas DG, et al. Association of Dasatinib with Progression-Free Survival among Patients with Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib. JAMA Oncol. 2018;4(6):814-820. PMID: 29710216. PMC6145709.
  56. Shah PH, Alom MA, Leibovich BC, et al. The Temporal Association of Robotic Surgical Diffusion with Overtreatment of the Small Renal Mass. J Urol. 2018. PMID: 29792881.
  57. Shi X, Ba R, You H, et al. A Rare Case of B-Lymphoproliferative Disorder with Villous Lymphocytes Harboring T(8;14)(Q24;Q32) Translocation. Front Med. 2018;12(3):324-329. PMID: 29075958.
  58. Siminoff LA, Wilson-Genderson M, Gardiner HM, Mosavel M, Barker KL. Consent to a Postmortem Tissue Procurement Study: Distinguishing Family Decision Makers’ Knowledge of the Genotype-Tissue Expression Project. Biopreserv Biobank. 2018. PMID: 29746160. PMC5995262.
  59. Sun M, Marconi L, Eisen T, et al. Adjuvant Vascular Endothelial Growth Factor-Targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis. Eur Urol. 2018. PMID: 29784193.
  60. Sun Y, Johnson C, Zhou J, et al. Uremic Toxins Are Conditional Danger- or Homeostasis-Associated Molecular Patterns. Front Biosci (Landmark Ed). 2018;23:348-387. PMID: 28930551. PMC5627515. NIHMS907864.
  61. Tan CRC, Abdul-Majeed S, Cael B, Barta SK. Clinical Pharmacokinetics and Pharmacodynamics of Bortezomib. Clin Pharmacokinet. 2018. PMID: 29802543.
  62. Tang B, Lee HO, An SS, Cai KQ, Kruger WD. Specific Targeting of Mtap-Deleted Tumors with a Combination of 2′-Fluoroadenine and 5′-Methylthioadenosine. Cancer Res. 2018;78(15):4386-4395. PMID: 29844120. PMC6072572.
  63. Timmerman RD, Paulus R, Pass HI, et al. Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings from the Nrg Oncology Rtog 0618 Trial. JAMA Oncol. 2018;4(9):1263-1266. PMID: 29852037. PMC6117102.
  64. von Massenhausen A, Tonnus W, Himmerkus N, et al. Correction To: Phenytoin Inhibits Necroptosis. Cell Death Dis. 2018;9(6):622. PMID: 29795371. PMC5967310.
  65. von Mehren M, Randall RL, Benjamin RS, et al. Soft Tissue Sarcoma, Version 2.2018, Nccn Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(5):536-563. PMID: 29752328.
  66. Vyfhuis MAL, Bhooshan N, Molitoris J, et al. Corrigendum to “Clinical Outcomes of Black Vs. Non-Black Patients with Locally Advanced Non-Small Cell Lung Cancer” [Lung Cancer 114, (December 2017) 44-49]. Lung Cancer. 2018;116:105. PMID: 29289353.
  67. Warner WA, Lee TY, Fang F, et al. The Burden of Prostate Cancer in Trinidad and Tobago: One of the Highest Mortality Rates in the World. Cancer Causes Control. 2018;29(7):685-697. PMID: 29774450. PMC5999193. https://www.ncbi.nlm.nih.gov/pubmed/29774450
  68. Whelan KA, Muir AB, Nakagawa H. Esophageal 3d Culture Systems as Modeling Tools in Esophageal Epithelial Pathobiology and Personalized Medicine. Cell Mol Gastroenterol Hepatol. 2018;5(4):461-478. PMID: 29713660. PMC5924738.
  69. Wong YN, Manola J, Hudes GR, et al. Phase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: Ecog-Acrin Cancer Research Group (E1898) Trial. Clin Genitourin Cancer. 2018;16(2):e315-e322. PMID: 29173976. PMC5975965.
  70. Zarin P, In TS, Chen EL, et al. Integration of T-Cell Receptor, Notch and Cytokine Signals Programs Mouse Gammadelta T-Cell Effector Differentiation. Immunol Cell Biol. 2018. PMID: 29754419.

Staff Publications: April 2018

  1. Abbas AM, Strong AT, Diehl DL, et al. Multicenter Evaluation of the Clinical Utility of Laparoscopy-Assisted Ercp in Patients with Roux-En-Y Gastric Bypass. Gastrointest Endosc. 2018;87(4):1031-1039. PMID: 29129525.
  2. Adolf-Bryfogle J, Kalyuzhniy O, Kubitz M, et al. Rosettaantibodydesign (RAbD): A General Framework for Computational Antibody Design. PLoS Comput Biol. 2018;14(4):e1006112. PMID: 29702641. PMC5942852.
  3. Autieri MV. Il-19 and Other Il-20 Family Member Cytokines in Vascular Inflammatory Diseases. Front Immunol. 2018;9:700. PMID: 29681905. PMC5897441.
  4. Benson AB, 3rd, Venook AP, Al-Hawary MM, et al. NCCN Guidelines Insights: Colon Cancer, Version 2.2018. J Natl Compr Canc Netw. 2018;16(4):359-369. PMID: 29632055.
  5. Borghaei H, Yim YM, Guerin A, et al. Severe Adverse Events Impact Overall Survival and Costs in Elderly Patients with Advanced Non-Small Cell Lung Cancer on Second-Line Therapy. Lung Cancer. 2018;119:112-119. PMID: 29656745.
  6. Cahn DB, Foote C, Smaldone MC. Challenges Facing Regionalization of Radical Cystectomy. Transl Androl Urol. 2018;7(2):292-294. PMID: 29733077. PMC5911529.
  7. Cohen SJ, Zalupski MM, Conkling P, et al. A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients with Metastatic Chemotherapy-Naive Pancreatic Adenocarcinoma. Am J Clin Oncol. 2018;41(3):230-235. PMID: 26709865.
  8. Correa AF, Smaldone MC. Melancholia and Cancer: The Bladder Cancer Narrative. Cancer. 2018;124(15):3080-3083. PMID: 29660788.
  9. Cueto R, Zhang L, Shan HM, et al. Identification of Homocysteine-Suppressive Mitochondrial Etc Complex Genes and Tissue Expression Profile – Novel Hypothesis Establishment. Redox Biol. 2018;17:70-88. PMID: 29679893. PMC6006524.
  10. Dolman GE, Koffas A, Mason WS, Kennedy PT. Why, Who and When to Start Treatment for Chronic Hepatitis B Infection. Curr Opin Virol. 2018;30:39-47. PMID: 29655092.
  11. Doss M. Radiation Dose from Cardiac Catheterization Procedures in Young Patients May Not Contribute to Increased Cancer Risk. Eur J Epidemiol. 2018;33(4):425-426. PMID: 29616389.
  12. Edwards DC, Cahn DB, Smaldone MC, Kutikov A. Use of Administrative Data for Comparative Effectiveness Research in the Treatment of Non-Prostate Genitourinary Malignancies. Urol Oncol. 2018;36(4):193-212. PMID: 28867432.
  13. Fahl SP, Wiest DL. Reply to Chien: Clarification of the Effect of Ligand on γδ-TCR Repertoire Selection. Proc Natl Acad Sci USA. 2018;115(16):E3607-E3608. PMID: 29615510. PMC5910880.
  14. Gajra A, Zemla TJ, Jatoi A, et al. Time-to-Treatment-Failure and Related Outcomes among 1000+ Advanced Non-Small Cell Lung Cancer Patients: Comparisons between Older Versus Younger Patients (Alliance A151711). J Thorac Oncol. 2018;13(7):996-1003. PMID: 29608967. PMC6015776.
  15. Geynisman DM, Meeker CR, Doyle JL, et al. Provider and Patient Burdens of Obtaining Oral Anticancer Medications. Am J Manag Care. 2018;24(4):e128-e133. PMID: 29668216.
  16. Gianti E, Delemotte L, Klein ML, Carnevale V. On the Role of Water Density Fluctuations in the Inhibition of a Proton Channel. Proc Natl Acad Sci USA. 2016;113(52):E8359-E8368. PMID: 27956641. PMC5206518.
  17. Giri VN, Obeid E, Hegarty SE, et al. Understanding of Multigene Test Results among Males Undergoing Germline Testing for Inherited Prostate Cancer: Implications for Genetic Counseling. Prostate. 2018;78(12):879-888. PMID: 29655297. PMC6047906.
  18. Gray PN, Tsai P, Chen D, et al. TumorNext-Lynch-MMR: A Comprehensive Next Generation Sequencing Assay for the Detection of Germline and Somatic Mutations in Genes Associated with Mismatch Repair Deficiency and Lynch Syndrome. Oncotarget. 2018;9(29):20304-20322. PMID: 29755653. PMC5945525.
  19. Gu J, Maxwell AE, Ma GX, et al. Evaluating the Training of Chinese-Speaking Community Health Workers to Implement a Small-Group Intervention Promoting Mammography. J Cancer Educ. 2018. PMID: 29654506.
  20. Hall TM, Tetreault MP, Hamilton KE, Whelan KA. Autophagy as a Cytoprotective Mechanism in Esophageal Squamous Cell Carcinoma. Curr Opin Pharmacol. 2018;41:12-19. PMID: 29677645. PMC6108938.
  21. Hassett MJ, Jiang W, Hughes ME, et al. Treating Second Breast Events after Breast-Conserving Surgery for Ductal Carcinoma in Situ. J Natl Compr Canc Netw. 2018;16(4):387-394. PMID: 29632058.
  22. Heckman CJ, Handorf E, Auerbach MV. Prevalence and Correlates of Skin Cancer Screening among Indoor Tanners and Nontanners. JAMA Dermatol. 2018;154(5):554-560. PMID: 29617518. PMC6128499.
  23. Hellmann MD, Ciuleanu TE, Pluzanski A, et al. Nivolumab Plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden. N Engl J Med. 2018;378(22):2093-2104. PMID: 29658845.
  24. Hellmann MD, Nathanson T, Rizvi H, et al. Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer. Cancer Cell. 2018;33(5):843-852 e844. PMID: 29657128. PMC5953836.
  25. Hernandez Borrero LJ, Sikder R, Lulla A, et al. Bcl-2 Protein Targeting by the P53/P21 Complex-Letter. Cancer Res. 2018;78(10):2770-2771. PMID: 29703721.
  26. Hernandez-Borrero LJ, Zhang S, Lulla A, Dicker DT, El-Deiry WS. CB002, a Novel P53 Tumor Suppressor Pathway-Restoring Small Molecule Induces Tumor Cell Death through the Pro-Apoptotic Protein NOXA. Cell Cycle. 2018;17(5):557-567. PMID: 28749203. PMC5969548.
  27. Houghton LC, Knight JA, De Souza MJ, et al. Comparison of Methods to Assess Onset of Breast Development in the Legacy Girls Study: Methodological Considerations for Studies of Breast Cancer. Breast Cancer Res. 2018;20(1):33. PMID: 29669587. PMC5907380.
  28. Ingram JP, Tursi S, Zhang T, et al. A Nonpyroptotic Ifn-Gamma-Triggered Cell Death Mechanism in Nonphagocytic Cells Promotes Salmonella Clearance in Vivo. J Immunol. 2018;200(10):3626-3634. PMID: 29654208. PMC6034694.
  29. Jalagadugula G, Goldfinger LE, Mao G, Lambert MP, Rao AK. Defective RAB1B-Related Megakaryocytic Er-to-Golgi Transport in Runx1 Haplodeficiency: Impact on Von Willebrand Factor. Blood Adv. 2018;2(7):797-806. PMID: 29632235. PMC5894258.
  30. Jonasch E, Slack RS, Geynisman DM, et al. Phase II Study of Two Weeks on, One Week Off Sunitinib Scheduling in Patients with Metastatic Renal Cell Carcinoma. J Clin Oncol. 2018;36(16):1588-1593. PMID: 29641297.
  31. Kaiser CE, Rincon Pabon JP, Khowsathit J, et al. Modulating Antibody Structure and Function through Directed Mutations and Chemical Rescue. ACS Synth Biol. 2018;7(4):1152-1162. PMID: 29609459. PMC5910032. NIHMS958000.
  32. Kamboj M, Brite J, Aslam A, et al. Artificial Differences in Clostridium Difficile Infection Rates Associated with Disparity in Testing. Emerg Infect Dis. 2018;24(3):584-587. PMID: 29460760. PMC5823336.
  33. Kasivisvanathan V, Kutikov A, Manning TG, et al. Safeguarding the Future of Urological Research and Delivery of Clinical Excellence by Harnessing the Power of Youth to Spearhead Urological Research. Eur Urol. 2018;73(5):645-647. PMID: 29128207.
  34. Kearns AC, Robinson JA, Shekarabi M, Liu F, Qin X, Burdo TH. Caspase-1-Associated Immune Activation in an Accelerated SIV-Infected Rhesus Macaque Model. J Neurovirol. 2018;24(4):420-431. PMID: 29611111.
  35. Khatri NV, Patel B, Kohli DR, Solomon SS, Bull-Henry K, Kessler CM. Lenalidomide as a Novel Therapy for Gastrointestinal Angiodysplasia in Von Willebrand Disease. Haemophilia. 2018;24(2):278-282. PMID: 29446520.
  36. Kornblum N, Zhao F, Manola J, et al. Randomized Phase Ii Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of Pre0102. J Clin Oncol. 2018;36(16):1556-1563. PMID: 29664714.
  37. Kumar S, Patel R. Neutral Theory, Disease Mutations, and Personal Exomes. Mol Biol Evol. 2018;35(6):1297-1303. PMID: 29688514. PMC5967454.
  38. McIntosh AG, Ristau BT, Ruth K, et al. Active Surveillance for Localized Renal Masses: Tumor Growth, Delayed Intervention Rates, and >5-Yr Clinical Outcomes. Eur Urol. 2018;74(2):157-164. PMID: 29625756.
  39. Mehrazin R, Dulaimi E, Uzzo RG, et al. The Correlation between Gain of Chromosome 8q and Survival in Patients with Clear and Papillary Renal Cell Carcinoma. Ther Adv Urol. 2018;10(1):3-10. PMID: 29344091. PMC5761913.
  40. Milano RV, Viale E, Bartel MJ, Notaristefano C, Testoni PA. Resection Outcomes and Recurrence Rates of Endoscopic Submucosal Dissection (ESD) and Hybrid ESD for Colorectal Tumors in a Single Italian Center. Surg Endosc. 2018;32(5):2328-2339. PMID: 29098434.
  41. Mishra OP, Popov AV, Pietrofesa RA, Nakamaru-Ogiso E, Andrake M, Christofidou-Solomidou M. Synthetic Secoisolariciresinol Diglucoside (LGM2605) Inhibits Myeloperoxidase Activity in Inflammatory Cells. Biochim Biophys Acta Gen Subj. 2018;1862(6):1364-1375. PMID: 29524540. PMC5970065.
  42. Moore KN, Martin LP, O’Malley DM, et al. A Review of Mirvetuximab Soravtansine in the Treatment of Platinum-Resistant Ovarian Cancer. Future Oncol. 2018;14(2):123-136. PMID: 29098867.
  43. Morgans AK, Chen YH, Sweeney CJ, et al. Quality of Life During Treatment with Chemohormonal Therapy: Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate Cancer. J Clin Oncol. 2018;36(11):1088-1095. PMID: 29522362. PMC5891128.
  44. Mortazavi SMJ. Commentary: Geographic Variations in the Incidence of Glioblastoma and Prognostic Factors Predictive of Overall Survival in US Adults from 2004-2013. Front Aging Neurosci. 2018;10:105. PMID: 29708188. PMC5906709.
  45. Mortazavi SMJ. Comments on “Radiological Protection for Pregnant Women at a Large Academic Medical Cancer Center”. Phys Med. 2018;47:144. PMID: 29032028.
  46. Mortazavi SMJ. Shortcomings of the Immunological Model of Carcinogenesis. Proc Natl Acad Sci USA. 2018;115(19):E4318. PMID: 29669916. PMC5949006.
  47. Mortazavi SMJ, Mortazavi G. Re: Blood Mercury Concentration in Relation to Metabolic and Weight Phenotypes Using the KNHANES 2011-2013 Data. Int Arch Occup Environ Health. 2018;91(2):247. PMID: 29273973.
  48. Peng H, Prokop J, Karar J, et al. Familial and Somatic BAP1 Mutations Inactivate ASXL1/2-Mediated Allosteric Regulation of BAP1 Deubiquitinase by Targeting Multiple Independent Domains. Cancer Res. 2018;78(5):1200-1213. PMID: 29284740. PMC6167014.
  49. Perera M, Al-Hebshi NN, Perera I, et al. Inflammatory Bacteriome and Oral Squamous Cell Carcinoma. J Dent Res. 2018;97(6):725-732. PMID: 29630846.
  50. Punglia RS, Jiang W, Lipsitz SR, et al. Clinical Risk Score to Predict Likelihood of Recurrence after Ductal Carcinoma in Situ Treated with Breast-Conserving Surgery. Breast Cancer Res Treat. 2018;167(3):751-759. PMID: 29079937.
  51. Ray M, Gabunia K, Vrakas CN, et al. Genetic Deletion of IL-19 (Interleukin-19) Exacerbates Atherogenesis in IL
  52. 19(-/-)Xldlr(-/-) Double Knockout Mice by Dysregulation of Mrna Stability Protein Hur (Human Antigen R). Arterioscler Thromb Vasc Biol. 2018;38(6):1297-1308. PMID: 29674474. PMC5970062.
  53. Reese JB, Handorf E, Haythornthwaite JA. Sexual Quality of Life, Body Image Distress, and Psychosocial Outcomes in Colorectal Cancer: A Longitudinal Study. Support Care Cancer. 2018;26(10):3431-3440. PMID: 29679138.
  54. Regine WF, Winter K, Abrams RA, et al. Postresection CA19-9 and Margin Status as Predictors of Recurrence after Adjuvant Treatment for Pancreatic Carcinoma: Analysis of NRG Oncology RTOG Trial 9704. Adv Radiat Oncol. 2018;3(2):154-162. PMID: 29904740. PMC6000159.
  55. Remakus S, Ma X, Tang L, et al. Cutting Edge: Protection by Antiviral Memory CD8 T Cells Requires Rapidly Produced Antigen in Large Amounts. J Immunol. 2018;200(10):3347-3352. PMID: 29643193. PMC5940544.
  56. Ristau BT, Smaldone MC. Extended Venous Thromboembolism Prophylaxis after Radical Cystectomy: A Call for Adherence to Current Guidelines. Editorial Comment. Journal of Urology. 2018;199(4):914-914.
  57. Rudat S, Pfaus A, Cheng YY, et al. Ret-Mediated Autophagy Suppression as Targetable Co-Dependence in Acute Myeloid Leukemia. Leukemia. 2018;32(10):2189-2202. PMID: 29654265.
  58. Shah T, Lippman R, Kohli D, Mutha P, Solomon S, Zfass A. Accuracy of Probe-Based Confocal Laser Endomicroscopy (PCLE) Compared to Random Biopsies During Endoscopic Surveillance of Barrett’s Esophagus. Endosc Int Open. 2018;6(4):E414-E420. PMID: 29607393. PMC5876024.
  59. Smith EP, Li H, Friedberg JW, et al. Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703). Biol Blood Marrow Transplant. 2018;24(4):700-707. PMID: 29289757. PMC5965270.
  60. Steffen LE, Vowles KE, Smith BW, Gan GN, Edelman MJ. Daily Diary Study of Hope, Stigma, and Functioning in Lung Cancer Patients. Health Psychol. 2018;37(3):218-227. PMID: 29172604. PMC5837918.
  61. Thomson MD, Siminoff LA. Managing Work and Cancer Treatment: Experiences among Survivors of Hematological Cancer. Cancer. 2018;124(13):2824-2831. PMID: 29660822. PMC6070342.
  62. Ujjani C, Wang H, Skarbnik A, et al. A Phase 1 Study of Lenalidomide and Ibrutinib in Combination with Rituximab in Relapsed and Refractory CLL. Blood Adv. 2018;2(7):762-768. PMID: 29610115. PMC5894261.
  63. von Mehren M, Joensuu H. Gastrointestinal Stromal Tumors. J Clin Oncol. 2018;36(2):136-143. PMID: 29220298.
  64. Wang HH, Wu ZQ, Qian D, et al. Ablative Hypofractionated Radiation Therapy Enhances Non-Small Cell Lung Cancer Cell Killing via Preferential Stimulation of Necroptosis in Vitro and in Vivo. Int J Radiat Oncol Biol Phys. 2018;101(1):49-62. PMID: 29619976.
  65. Wolf SM, Scholtes E, Koenig BA, et al. Pragmatic Tools for Sharing Genomic Research Results with the Relatives of Living and Deceased Research Participants. J Law Med Ethics. 2018;46(1):87-109. PMID: 30008546. PMC6040667.
  66. Wood DE, Kazerooni EA, Baum SL, et al. Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(4):412-441. PMID: 29632061.
  67. Yadav J, Korzekwa K, Nagar S. Improved Predictions of Drug-Drug Interactions Mediated by Time-Dependent Inhibition of Cyp3a. Mol Pharm. 2018;15(5):1979-1995. PMID: 29608318. PMC5938745.
  68. Zaorsky NG, Keith SW, Shaikh T, et al. Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities. Am J Clin Oncol. 2018;41(4):409-415. PMID: 27014930.
  69. Zhang BW, Cui D, Matubayasi N, Levy RM. The Excess Chemical Potential of Water at the Interface with a Protein from End Point Simulations. J Phys Chem B. 2018;122(17):4700-4707. PMID: 29634902. PMC5939383.